Protein,Protein_definition,Trait_category,Trait,sample_size,Estimated_effect,se,lowerCI,upperCI,Pvalue
PON2,Serum paraoxonase/arylesterase 2,Lifestyle factors,X1050.Time spend outdoors in summer,49897,0.0497420484780403,0.0344477641044854,-0.0177755691667511,0.117259666122832,0.148757955977733
PON2,Serum paraoxonase/arylesterase 2,Lifestyle factors,X1060.Time spent outdoors in winter,47747,0.0248243410695602,0.0382637049519607,-0.0501725206362829,0.0998212027754032,0.516494879632341
PON2,Serum paraoxonase/arylesterase 2,Physical activities,X1070.Time spent watching television (TV),50681,0.13909412492426,0.034142367481184,0.0721750846611397,0.206013165187381,4.63848077290334e-05
PON2,Serum paraoxonase/arylesterase 2,Physical activities,X1080.Time spent using computer,47766,-0.103301614445078,0.0341544994507143,-0.170244433368478,-0.0363587955216784,0.00249342101896709
PON2,Serum paraoxonase/arylesterase 2,Physical activities,X1090.Time spent driving,45084,0.0552789504933497,0.0374851952564175,-0.0181920322092286,0.128749933195928,0.140315665647609
PON2,Serum paraoxonase/arylesterase 2,Lifestyle factors,X1160.Sleep duration,51731,-0.0473299187106977,0.0312565071357303,-0.108592672696729,0.0139328352753337,0.129978113868019
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X120039#0.Location of pain during the past week_None of the given areas,35899,-0.0306634748809863,0.0148329792918932,-0.059736114293097,-0.00159083546887554,0.0387457823382502
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X120039#1.Location of pain during the past week_Left shoulder,35899,0.00895522696324586,0.0164124469634668,-0.0232131690851491,0.0411236230116409,0.585332635520707
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X120039#10.Location of pain during the past week_Upper right leg,35899,0.00546474901460025,0.0173785992320712,-0.0285973054802593,0.0395268035094598,0.753186154884238
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X120039#11.Location of pain during the past week_Lower left leg,35899,-0.0159343847626711,0.0177910067983638,-0.0508047580874643,0.018935988562122,0.370473176121124
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X120039#12.Location of pain during the past week_Lower right leg,35899,-0.00830948849947763,0.0182177017402504,-0.0440161839103684,0.0273972069114131,0.64831606028204
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X120039#13.Location of pain during the past week_Left jaw pain,35899,0.0190743872408673,0.0478291034205802,-0.0746706554634699,0.112819429945204,0.690050074065098
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X120039#14.Location of pain during the past week_Right jaw pain,35899,-0.0114223187604389,0.0578847198967136,-0.124876369757998,0.10203173223712,0.843575785897259
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X120039#15.Location of pain during the past week_Chest pain,35899,0.0250034758116357,0.0286913368808254,-0.0312315444747821,0.0812384960980535,0.38352935305815
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X120039#16.Location of pain during the past week_Abdomen,35899,0.000534970616191251,0.0219585278557049,-0.0425037439809903,0.0435736852133728,0.980563908819316
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X120039#17.Location of pain during the past week_Neck pain,35899,0.00702336384009824,0.0149448402263193,-0.0222685230034876,0.0363152506836841,0.638403051085367
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X120039#18.Location of pain during the past week_Upper back,35899,-0.0430426820086142,0.0236901922868526,-0.0894754588908453,0.00339009487361683,0.0692736027384252
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X120039#19.Location of pain during the past week_Lower back,35899,-0.0168075848405817,0.0111041415678601,-0.0385717023135876,0.0049565326324242,0.130162478793998
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X120039#2.Location of pain during the past week_Right shoulder,35899,-0.00711218919402027,0.0153272906992141,-0.0371536789644798,0.0229293005764393,0.642646330966532
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X120039#3.Location of pain during the past week_Upper left arm,35899,-0.014030402089003,0.0242424779688976,-0.0615456589080423,0.0334848547300364,0.562773839087811
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X120039#4.Location of pain during the past week_Upper right arm,35899,-0.0520474393718736,0.0225186960168588,-0.0961840835649169,-0.00791079517883028,0.0208440644076366
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X120039#5.Location of pain during the past week_Lower left arm,35899,0.054485932336884,0.0276537052416916,0.000284670063168423,0.1086871946106,0.0488424135396691
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X120039#6.Location of pain during the past week_Lower right arm,35899,-0.00731364593750738,0.0273023177420419,-0.0608261887119095,0.0461988968368947,0.788802047779533
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X120039#7.Location of pain during the past week_Left hip,35899,0.00353430423430859,0.0170655119469593,-0.0299140991817316,0.0369827076503488,0.835935859382415
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X120039#8.Location of pain during the past week_Right hip,35899,-0.012767177914542,0.0166868575593236,-0.0454734187308162,0.0199390629017322,0.444234481788295
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X120039#9.Location of pain during the past week_Upper left leg,35899,0.00257790328537014,0.0184594811437506,-0.0336026797563811,0.0387584863271214,0.888938813691564
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X120040.Fatigue severity over the past week,35904,0.0597262555521053,0.058357891447979,-0.0546552116859335,0.174107722790144,0.306130073300179
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X120041.Waking unrefreshed severity over the past week,35907,0.0179163294403575,0.0576792773347423,-0.0951350541357375,0.130967713016452,0.756098484328652
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X120042.Cognitive symptoms severity over the past week,35907,0.00628744836589378,0.0634016217549208,-0.117979730273751,0.130554627005538,0.92100714788837
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X120098.Mobility problems today,35909,-0.0346293847025605,0.0671189876684851,-0.166182600532791,0.0969238311276703,0.605911780928588
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X120099.Self-care problems today,35909,-0.113265869820107,0.101870007279092,-0.312931084087128,0.0863993444469134,0.266232049572629
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X120100.Problems doing usual activities,35909,-0.0674503946014457,0.0650971901382603,-0.195040887272436,0.0601400980695446,0.300166884196639
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X120101.Pain or discomfort today,35909,-0.0412074695718209,0.0578365767932773,-0.154567160086644,0.0721522209430025,0.476189644965394
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X120102.Anxiety or depression today,35909,-0.0216614281512543,0.0740958581045733,-0.166889310036218,0.123566453733709,0.770032451756291
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X120103.Scale to indicate how health is today,35892,0.00279029509533714,0.00486352783201294,-0.00674221945540824,0.0123228096460825,0.566176112098195
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X120104.Little interest or pleasure in doing things over the last two weeks,35894,0.051286871348122,0.0724837117606644,-0.0907812037027802,0.193354946399024,0.479238614021992
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,"X120105.Feeling down, depressed, or hopeless over the last two weeks",35892,-0.0145486160015739,0.0771765831522973,-0.165814718980076,0.136717486976929,0.850481532172315
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,"X120106.Trouble falling or staying asleep, or sleeping too much over the last two weeks",35897,-0.0244269501163563,0.058985419629002,-0.1400383725892,0.0911844723564877,0.67879954190632
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X120107.Feeling tired or having little energy over the last two weeks,35902,-0.0363726289900345,0.0594150433261001,-0.152826113909191,0.0800808559291218,0.540438543372955
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X120108.Poor appetite or overeating over the last two weeks,35901,0.0911047658162248,0.0853953056756219,-0.0762700333079941,0.258479564940444,0.286070715753408
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X120109.Feeling bad about self over the last two weeks,35886,0.0731015288458548,0.0818443726936755,-0.0873134416337491,0.233516499325459,0.371791785660876
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X120110.Trouble concentrating over the last two weeks,35905,-0.000262638769856427,0.0777201729956005,-0.152594177841233,0.15206890030152,0.997303816511261
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X120111.Moving or speaking slower or faster than usual over the last two weeks,35897,0.0625892812524919,0.113150395582415,-0.159185494089041,0.284364056594025,0.580176805062707
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X120112.Thoughts of being better off dead or of hurting self over the last two weeks,35862,0.15840649482076,0.156891635201233,-0.149101110173657,0.465914099815177,0.312694040940677
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,"X120113.Level of difficultly depression has made to do work, take care of things at home, or get along with other people",33139,-0.0881992734220567,0.081685231001509,-0.248302326185014,0.071903779340901,0.28031285153424
PON2,Serum paraoxonase/arylesterase 2,Lifestyle factors,X1269.Exposure to tobacco smoke at home,49261,0.217461639596004,0.0746889910908849,0.0710712170578692,0.363852062134138,0.00360010834448543
PON2,Serum paraoxonase/arylesterase 2,Lifestyle factors,X1279.Exposure to tobacco smoke outside home,48051,0.0339874675533141,0.0433845967073833,-0.0510463419931572,0.119021277099785,0.433402140231235
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X1289.Cooked vegetable intake,50816,-0.216418372130263,0.0328092925348164,-0.280724585498504,-0.152112158762023,4.31166912473286e-11
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X1299.Salad  or  raw vegetable intake,49992,-0.214145832226651,0.033755599575326,-0.28030680739429,-0.147984857059012,2.28346614851231e-10
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X1309.Fresh fruit intake,50671,-0.269459851926855,0.0345545186907908,-0.337186708560805,-0.201732995292905,6.56152670582578e-15
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X1319.Dried fruit intake,49690,-0.272919284025888,0.0367445483613309,-0.344938598814096,-0.200899969237679,1.14896705700661e-13
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X134.Number of self-reported cancers,51876,0.0771984736924821,0.0687566694629928,-0.0575645984549838,0.211961545839948,0.261543386872503
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X135.Number of self-reported non-cancer illnesses,51877,-0.0310580694565657,0.0327063837484253,-0.0951625816034793,0.0330464426903479,0.342324038766503
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,"X136.Number of operations, self-reported",51877,-0.0151836109737606,0.0312767223201369,-0.0764859867212289,0.0461187647737077,0.627354346606267
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X137.Number of treatments or medications taken,51877,-0.0524377314905856,0.0319004811431612,-0.114962674531181,0.0100872115500102,0.100232836899542
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X1438.Bread intake,51337,-0.00758166419976418,0.00266184830880875,-0.0127988868850293,-0.00236444151449903,0.00439969654522654
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X1458.Cereal intake,50685,-0.237581882550047,0.0325696466593789,-0.30141839000243,-0.173745375097665,3.09704680350757e-13
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X1488.Tea intake,51013,-0.00853417346005476,0.00260958249913737,-0.013648955158364,-0.00341939176174551,0.00107587455484802
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X1498.Coffee intake,50066,0.0213811231987482,0.0323879733849997,-0.0420993046358512,0.0848615510333477,0.509160645324216
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X1528.Water intake,49763,-0.200210723158666,0.033045975786338,-0.264980835699889,-0.135440610617444,1.39674158982329e-09
PON2,Serum paraoxonase/arylesterase 2,Lifestyle factors,X1568.Average weekly red wine intake,46333,-0.189287023058697,0.0362910798416353,-0.260417539548302,-0.118156506569092,1.85082920853974e-07
PON2,Serum paraoxonase/arylesterase 2,Lifestyle factors,X1578.Average weekly champagne plus white wine intake,46325,-0.00643494435475591,0.0378409200920369,-0.0806031477351482,0.0677332590256364,0.864970762895449
PON2,Serum paraoxonase/arylesterase 2,Lifestyle factors,X1588.Average weekly beer plus cider intake,46394,0.0999753221385338,0.0377167275615439,0.0260505361179078,0.17390010815916,0.00803988242067231
PON2,Serum paraoxonase/arylesterase 2,Lifestyle factors,X1598.Average weekly spirits intake,46325,-0.00525797525276975,0.0391902787480825,-0.0820709215990114,0.0715549710934719,0.893273392804909
PON2,Serum paraoxonase/arylesterase 2,Lifestyle factors,X1608.Average weekly fortified wine intake,46362,0.0666590609659115,0.0697836484228239,-0.0701168899428233,0.203435011874646,0.339477104707955
PON2,Serum paraoxonase/arylesterase 2,Lifestyle factors,X1737.Childhood sunburn occasions,45733,-0.087010058791252,0.0384376012048098,-0.162347757152679,-0.0116723604298248,0.0236068490571393
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X1807.Father's age at death,45939,0.00178753527981311,0.00303374911945416,-0.00415861299431703,0.00773368355394326,0.555723673003207
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X1845.Mother's age,37173,-0.011230428631867,0.0067957501303694,-0.024550098887391,0.00208924162365701,0.0984557504253664
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X1873.Number of full brothers,51471,0.0349166355405239,0.0314896706580882,-0.0268031189493289,0.0966363900303767,0.267515952964846
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X1883.Number of full sisters,51473,-0.0240684014627229,0.0315179257693814,-0.0858435359707105,0.0377067330452646,0.445088686876243
PON2,Serum paraoxonase/arylesterase 2,Physical measures,X20015.Sitting height,51677,-0.0105201511226761,0.00342474970971641,-0.0172326605537203,-0.00380764169163192,0.00213018813834219
PON2,Serum paraoxonase/arylesterase 2,Cognitive function,X20016.Fluid intelligence score,36032,-0.0644023026280728,0.0519051906281484,-0.166136476259244,0.0373318710030981,0.214730672350573
PON2,Serum paraoxonase/arylesterase 2,Cognitive function,X20018.Prospective memory result,36377,0.0391039699955067,0.0689409341696512,-0.0960202609770097,0.174228200968023,0.570588058359185
PON2,Serum paraoxonase/arylesterase 2,Physical measures,X20019.Speech-reception-threshold (SRT) estimate (left),35954,0.00431025992585119,0.00467127177392859,-0.00484543275104886,0.0134659526027512,0.356185193408552
PON2,Serum paraoxonase/arylesterase 2,Physical measures,X20021.Speech-reception-threshold (SRT) estimate (right),35958,0.00810688935752,0.00468902617721262,-0.00108360194981674,0.0172973806648567,0.0838677184010841
PON2,Serum paraoxonase/arylesterase 2,Cognitive function,X20023.Mean time to correctly identify matches,51576,0.00111077636285905,0.00269517744290897,-0.00417177142524252,0.00639332415096063,0.680244482396362
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X20107#1.Illnesses of father_Heart disease,48458,-0.00900364438462346,0.00599782395017898,-0.0207593793269743,0.00275209055772734,0.133332195610635
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X20107#10.Illnesses of father_Alzheimer's disease or dementia,48014,0.00783846223009593,0.0134242274169914,-0.0184730235072072,0.0341499479673991,0.559291578268336
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X20107#11.Illnesses of father_Parkinson's disease,47975,-0.011606427400311,0.0176515165006137,-0.0462033997415138,0.0229905449408918,0.510847060900404
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X20107#12.Illnesses of father_Severe depression,47999,0.012834208373597,0.0158298516128109,-0.0181923007875124,0.0438607175347064,0.417513532667107
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X20107#13.Illnesses of father_Prostate cancer,48020,0.00149601411969587,0.0106459186786477,-0.0193699864904537,0.0223620147298454,0.88824692609853
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X20107#2.Illnesses of father_Stroke,48193,-0.00359119463844237,0.00764342782984748,-0.0185723131849434,0.0113899239080587,0.638473954701481
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X20107#3.Illnesses of father_Lung cancer,48137,-0.000564699738565058,0.00967715109007315,-0.0195319158751084,0.0184025163979783,0.953467312366762
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X20107#4.Illnesses of father_Bowel cancer,48037,0.0385105674861929,0.0117849831692271,0.0154120004745077,0.0616091344978781,0.00108588023103274
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X20107#6.Illnesses of father_Chronic bronchitis or emphysema,48163,0.0175899152983111,0.00905907472785325,-0.000165871168281279,0.0353457017649035,0.0521889713673084
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X20107#8.Illnesses of father_High blood pressure,48248,0.000639832430291826,0.00678567129998605,-0.0126600833176808,0.0139397481782645,0.924878410587428
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X20107#9.Illnesses of father_Diabetes,48106,0.0127163616820898,0.00931175108969973,-0.00553467045372162,0.0309673938179013,0.172072388267916
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X20110#1.Illnesses of mother_Heart disease,49240,-0.00690083111969072,0.00713227852537979,-0.0208800970294351,0.00707843479005367,0.333280843569562
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X20110#10.Illnesses of mother_Alzheimer's disease or dementia,49083,0.00292875811304179,0.0100042211433469,-0.0166795153279181,0.0225370315540017,0.769714504672626
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X20110#11.Illnesses of mother_Parkinson's disease,49006,-0.0286648997850061,0.0222034052981729,-0.072183574169425,0.0148537745994128,0.196713562194062
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X20110#12.Illnesses of mother_Severe depression,49041,0.00569031402964744,0.0118478574744686,-0.017531486620311,0.0289121146796058,0.631031945013999
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X20110#2.Illnesses of mother_Stroke,49184,-0.0024163861952932,0.0079714607152489,-0.018040449197181,0.0132076768065946,0.761794113031298
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X20110#3.Illnesses of mother_Lung cancer,49084,0.00695887552114955,0.0133239046585661,-0.0191559776096401,0.0330737286519392,0.601477560650087
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X20110#4.Illnesses of mother_Bowel cancer,49049,0.0105105665659961,0.0121411843224628,-0.013286154706031,0.0343072878380232,0.386667417925813
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X20110#5.Illnesses of mother_Breast cancer,49058,-0.00385821274989173,0.0101788691906664,-0.0238087963635978,0.0160923708638143,0.704661060335142
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X20110#6.Illnesses of mother_Chronic bronchitis or emphysema,49088,0.00957830614939628,0.0121613353040507,-0.014257911046543,0.0334145233453356,0.430937975462427
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X20110#8.Illnesses of mother_High blood pressure,49288,0.00614649217743849,0.00613928365362096,-0.00588650378365859,0.0181794881385356,0.316754324761992
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X20110#9.Illnesses of mother_Diabetes,49141,-0.00201875251748428,0.00925406246458693,-0.0201567149480747,0.0161192099131061,0.827316193707306
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X20111#1.Illnesses of siblings_Heart disease,46235,-0.0134773671108259,0.00987580748803081,-0.0328339497873663,0.00587921556571444,0.172369463656878
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X20111#10.Illnesses of siblings_Alzheimer's disease or dementia,46091,-0.0247862596784656,0.0400365177516949,-0.103257834471788,0.0536853151148565,0.535864279721838
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X20111#11.Illnesses of siblings_Parkinson's disease,46085,0.0594019294486717,0.0394042654241655,-0.0178304307826927,0.136634289680036,0.131700614782323
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X20111#12.Illnesses of siblings_Severe depression,46139,-0.0115529428993194,0.0128307441332288,-0.0367012014004478,0.013595315601809,0.367913942491879
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X20111#13.Illnesses of siblings_Prostate cancer,46101,-0.02321904403869,0.022737561320275,-0.067784664226429,0.0213465761490489,0.307185340557027
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X20111#2.Illnesses of siblings_Stroke,46135,-0.00398078752343291,0.016467908958284,-0.0362578890816696,0.0282963140348037,0.808992213980351
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X20111#3.Illnesses of siblings_Lung cancer,46105,0.00500565543318233,0.0188179835157287,-0.0318775922576459,0.0418889031240105,0.790239402552394
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X20111#4.Illnesses of siblings_Bowel cancer,46109,0.0144292786835639,0.0183518435932613,-0.0215403347592282,0.050398892126356,0.431727158119315
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X20111#5.Illnesses of siblings_Breast cancer,46116,-0.014328135338029,0.0144905634217982,-0.0427296396447534,0.0140733689686954,0.322779180325216
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X20111#6.Illnesses of siblings_Chronic bronchitis or emphysema,46134,0.0203509016635511,0.0182840258007351,-0.0154857889058898,0.0561875922329919,0.265705344548033
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X20111#8.Illnesses of siblings_High blood pressure,46297,-0.0176860946346513,0.00748632931448848,-0.0323593000910487,-0.00301288917825385,0.0181652443917468
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X20111#9.Illnesses of siblings_Diabetes,46200,0.0157091994514801,0.0104490121338993,-0.00477086433096248,0.0361892632339226,0.132750055905681
PON2,Serum paraoxonase/arylesterase 2,Mental health,X20127.Neuroticism score,47366,0.049381382758298,0.0327241437932825,-0.0147579390765357,0.113520704593132,0.131310553707958
PON2,Serum paraoxonase/arylesterase 2,Cognitive function,X20128.Number of fluid intelligence questions attempted within time limit,36032,0.0190861081492982,0.052614446445965,-0.0840382068847932,0.12221042318339,0.716798885166176
PON2,Serum paraoxonase/arylesterase 2,Lifestyle factors,X20161.Pack years of smoking,36710,0.0214338744130163,0.00453461375883663,0.0125460314456965,0.0303217173803361,2.32014604513764e-06
PON2,Serum paraoxonase/arylesterase 2,Lifestyle factors,X20162.Pack years adult smoking as proportion of life span exposed to smoking,36710,0.0203111698121935,0.00447292474814856,0.0115442373058223,0.0290781023185647,5.68192170203301e-06
PON2,Serum paraoxonase/arylesterase 2,Cognitive function,X20191.Fluid intelligence score,34149,-0.0363272716923374,0.0609044492429394,-0.155699992208499,0.0830454488238239,0.5508901162894
PON2,Serum paraoxonase/arylesterase 2,Cognitive function,X20192.Number of fluid intelligence questions attempted within time limit,34150,-0.00130931792571543,0.0618895908794306,-0.122612916049399,0.119994280197969,0.983122210827216
PON2,Serum paraoxonase/arylesterase 2,Cognitive function,X20240.Maximum digits remembered correctly,33618,-0.00724176665817166,0.065186868751584,-0.135008029411276,0.120524496094933,0.911547513710193
PON2,Serum paraoxonase/arylesterase 2,Physical measures,X20255.Spirometry QC measure,45226,0.0668387024138765,0.0406905005652406,-0.012914678693995,0.146592083521748,0.10048215562419
PON2,Serum paraoxonase/arylesterase 2,Eye measures,X20261.avMSE,33703,0.00971106724314732,0.00576737027116488,-0.00159297848833584,0.0210151129746305,0.0922825213431069
PON2,Serum paraoxonase/arylesterase 2,Eye measures,X20262.Myopia diagnosis,33703,-0.104113614693528,0.0789078648908988,-0.258773029879689,0.0505458004926337,0.18708371245235
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X20280.Glucose-lactate,41872,0.0156665531537829,0.00332599598546813,0.00914760102226536,0.0221855052853004,2.4981719804467e-06
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X20281.Spectrometer-corrected alanine,41897,0.0101197339419105,0.00353047698204459,0.0031999990571031,0.0170394688267179,0.00415830406760592
PON2,Serum paraoxonase/arylesterase 2,Mental health,X20544#11.Mental health problems ever diagnosed by a professional_Depression,35807,-0.0372209255430799,0.0220446044495417,-0.0804283502641817,0.00598649917802195,0.0913706378394121
PON2,Serum paraoxonase/arylesterase 2,Mental health,X20544#6.Mental health problems ever diagnosed by a professional_Panic attacks,35807,-0.00510153415836845,0.0490648226262467,-0.101268586505812,0.0910655181890751,0.917191770316166
PON2,Serum paraoxonase/arylesterase 2,Mental health,X20546#1.Substances taken for depression_Unprescribed medication (more than once),35807,-0.0578053704351149,0.0595606167759892,-0.174544179316054,0.0589334384458239,0.331814906461248
PON2,Serum paraoxonase/arylesterase 2,Mental health,X20546#3.Substances taken for depression_Medication prescribed to you (for at least two weeks),35807,-0.0364835515953647,0.0214988963512995,-0.0786213884439117,0.00565428525318235,0.0897405036319363
PON2,Serum paraoxonase/arylesterase 2,Mental health,X20546#4.Substances taken for depression_Drugs or alcohol (more than once),35807,-0.0468441720189666,0.0302880807470473,-0.106208810283179,0.0125204662452462,0.121998647394269
PON2,Serum paraoxonase/arylesterase 2,Mental health,X20548#1.Manifestations of mania or irritability_I was more talkative than usual,35810,0.0376736037445276,0.0410816678496418,-0.0428464652407703,0.118193672729826,0.359151446266676
PON2,Serum paraoxonase/arylesterase 2,Mental health,X20548#2.Manifestations of mania or irritability_I was more restless than usual,35810,0.0179985252078071,0.0258115435553379,-0.0325921001606552,0.0685891505762694,0.485634257361408
PON2,Serum paraoxonase/arylesterase 2,Mental health,X20548#3.Manifestations of mania or irritability_My thoughts were racing,35810,0.00793108419995431,0.0297887902606746,-0.0504549447109679,0.0663171131108766,0.790058975565387
PON2,Serum paraoxonase/arylesterase 2,Mental health,X20548#5.Manifestations of mania or irritability_I needed less sleep than usual,35810,-0.0165986625818073,0.0429915533221815,-0.100862107093283,0.0676647819296685,0.699440481596165
PON2,Serum paraoxonase/arylesterase 2,Mental health,X20548#6.Manifestations of mania or irritability_I was more creative or had more ideas than usual,35810,0.00123840850998537,0.0476402012873956,-0.0921363860133099,0.0946132030332807,0.979262021195831
PON2,Serum paraoxonase/arylesterase 2,Mental health,X20548#7.Manifestations of mania or irritability_I was easily distracted,35810,-0.0180219075629672,0.03106694142369,-0.0789131127533996,0.0428692976274651,0.561865857289727
PON2,Serum paraoxonase/arylesterase 2,Mental health,X20548#8.Manifestations of mania or irritability_I was more confident than usual,35810,0.0187821136874103,0.0466611940426936,-0.0726738266362692,0.11023805401109,0.68731251932232
PON2,Serum paraoxonase/arylesterase 2,Mental health,X20548#9.Manifestations of mania or irritability_I was more active than usual,35810,0.0060707015755319,0.0378808790652574,-0.0681758213923726,0.0803172245434364,0.872682588414667
PON2,Serum paraoxonase/arylesterase 2,Mental health,X20549#1.Substances taken for anxiety_Unprescribed medication (more than once),35813,-0.123554939694989,0.064810592849663,-0.250583701680329,0.00347382229035061,0.0566379779724701
PON2,Serum paraoxonase/arylesterase 2,Mental health,X20549#3.Substances taken for anxiety_Medication prescribed to you (for at least two weeks),35813,-0.0428587931775073,0.0283763942363298,-0.0984765258807138,0.0127589395256992,0.130993394537065
PON2,Serum paraoxonase/arylesterase 2,Mental health,X20549#4.Substances taken for anxiety_Drugs or alcohol (more than once),35813,-0.0240334085449092,0.0368053564390547,-0.0961719071654564,0.048105090075638,0.513785659220011
PON2,Serum paraoxonase/arylesterase 2,Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,35813,0.0295338373857721,0.0789051524466766,-0.125120261409714,0.184187936181258,0.708195539655758
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20600.Liking for adding salt to foods,36474,0.0407498092791059,0.0522492665115868,-0.0616587530836042,0.143158371641816,0.43546637618235
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20601.Liking for aniseed,36474,-0.00267522335700972,0.0521039506254347,-0.104798966582862,0.0994485198688423,0.959052740072167
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20602.Liking for apple juice,36474,0.00206913686840095,0.0528065138481274,-0.101431630273929,0.105569904010731,0.968745191342821
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20603.Liking for apples,36474,0.0304141014417385,0.0532122041781289,-0.0738818187473942,0.134710021630871,0.567634727167009
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20604.Liking for asparagus,36474,-0.106395335909826,0.0526839267599379,-0.209655832359304,-0.0031348394603479,0.0434688407583781
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20605.Liking for aubergine,36474,-0.117275474090524,0.0522824783031072,-0.219749131564614,-0.0148018166164337,0.0249172982873587
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20606.Liking for avocados,36474,-0.141880505100261,0.0524904518236067,-0.24476179067453,-0.0389992195259917,0.00688690342470925
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20607.Liking for bacon,36474,0.117108663629716,0.0534431667303275,0.0123600568382741,0.221857270421158,0.0284611428630345
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20608.Liking for baked or steamed fish,36474,-0.0543595252486443,0.0526320735639362,-0.157518389433959,0.0487993389366707,0.301719303211929
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20609.Liking for bananas,36474,0.0622720189201172,0.053630330793059,-0.0428434294342784,0.167387467274513,0.245622509413247
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20610.Liking for barbequed or grilled meat,36474,-0.0216354392610478,0.0527478860027515,-0.125021295826441,0.0817504173043452,0.681694658998799
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20611.Liking for beef steak,36474,0.0661107421385274,0.0530921000925735,-0.0379497740429166,0.170171258319971,0.213092162361866
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20612.Liking for beetroot,36474,-0.00760808746529593,0.0527878723103511,-0.111072317193584,0.0958561422629923,0.885404927215546
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20613.Liking for bell pepper,36474,-0.0405734769861266,0.0527555447947036,-0.143974344783746,0.0628273908114924,0.441866185061001
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20614.Liking for bicycling,36474,-0.21984577641062,0.0525119456402601,-0.32276918986553,-0.11692236295571,2.86268665981321e-05
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20615.Liking for biscuits,36474,0.137447885604546,0.0524033322660414,0.0347373543631049,0.240158416845987,0.00873570137398218
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20616.Liking for bitter foods,36474,-0.0572037486280119,0.052225657309305,-0.15956603695425,0.0451585396982259,0.273410497311781
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20617.Liking for bitter or ale,36474,-0.0149501761273655,0.0528320712095601,-0.118501035698103,0.0886006834433722,0.777203146854799
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20618.Liking for black olives,36474,-0.0796439322925365,0.0524387467483198,-0.182423875919243,0.0231360113341704,0.128853214705663
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20619.Liking for black pepper,36474,-0.041453884927907,0.0527481546704839,-0.144840268082055,0.0619324982262415,0.431959633316914
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20620.Liking for blue cheese,36474,0.00882899814376251,0.05223085495744,-0.0935434775728199,0.111201473860345,0.865771115595383
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20621.Liking for bolognese sauce,36474,0.150640668471601,0.0525485404319673,0.0476455292249448,0.253635807718257,0.00415883270966279
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20622.Liking for broad beans,36474,-0.0461595637349831,0.051989218546403,-0.148058432085933,0.0557393046159668,0.374638907800458
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20623.Liking for broccoli,36474,-0.0544791003523915,0.0529676819357694,-0.1582957569465,0.0493375562417166,0.303729992852475
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20624.Liking for brown rice,36474,-0.16521494365966,0.0522240012556798,-0.267573986120792,-0.0628559011985279,0.00156433416150786
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20625.Liking for brussel sprouts,36474,-0.0775800344122126,0.052640056052464,-0.180754544275042,0.0255944754506168,0.140579972952316
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20626.Liking for burgers (meat),36474,0.0820225288734233,0.0525174098780082,-0.0209115944874727,0.184956652234319,0.118371584600952
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20627.Liking for burn of spicy foods,36474,-0.0385059896959536,0.0518201031419348,-0.140073391854146,0.0630614124622387,0.45746119574791
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20628.Liking for butter on bread,36474,0.130148336076663,0.0526537117307433,0.0269470610844065,0.23334961106892,0.0134652738360241
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20629.Liking for butternut squash,36474,-0.0761295406410537,0.0520077006891349,-0.178064633991758,0.0258055527096507,0.143285054406072
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20630.Liking for cabbage,36474,0.0362730593296938,0.0528077161833426,-0.0672300643896577,0.139776183049045,0.492172692478021
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20631.Liking for cake,36474,0.0858599614051163,0.0525746339284512,-0.017186321094648,0.188906243904881,0.102486687929904
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20632.Liking for cake icing,36474,0.0841517702809857,0.0517209848308472,-0.0172213599874747,0.185524900549446,0.103770060930294
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20633.Liking for capers,36474,-0.0265086752026924,0.0520466364647915,-0.128520082673684,0.0755027322682989,0.61053842893218
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20634.Liking for cauliflower,36474,-0.0654171999421558,0.0529792449959318,-0.169256520134182,0.0384221202498706,0.216952879359924
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20635.Liking for cereal or granola bar,36474,0.00127158759219131,0.0520855372175198,-0.100816065354148,0.10335924053853,0.98052344033733
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20636.Liking for cheesecake,36474,0.0772690271743165,0.052158762759468,-0.0249621478342407,0.179500202182874,0.138534785146996
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20637.Liking for cherries,36474,0.0409493935483056,0.0532928819058072,-0.0635046549870765,0.145403442083688,0.442282200436811
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20638.Liking for chicken,36474,0.0377127529217734,0.0546908059179556,-0.0694812266774196,0.144906732520966,0.490489423484828
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20639.Liking for chilli pepper,36474,0.032522069335488,0.0519364544093367,-0.0692733813068119,0.134317519977788,0.531208738246469
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20640.Liking for chips or french fries,36474,0.114634561398873,0.0527224018661549,0.0112986537412097,0.217970469056537,0.0297119792283907
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20641.Liking for cigarette smoking,36474,-0.137954738263715,0.0821347681196042,-0.29893888377814,0.023029407250709,0.0930720839757785
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20642.Liking for cod,36474,-0.00902062384304319,0.0543067854114169,-0.11546192324942,0.0974206755633339,0.868078657774015
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20643.Liking for coffee with sugar,36474,0.0893512711364588,0.0550815441541489,-0.0186085554056731,0.197311097678591,0.10480842323796
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20644.Liking for coffee without sugar,36474,-0.0300338962693547,0.0527207716030293,-0.133366608611292,0.0732988160725827,0.568911965660682
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20645.Liking for coriander,36474,-0.034261515016632,0.0519546034169356,-0.136092537713826,0.0675695076805618,0.509625511555049
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20646.Liking for corn flakes,36474,0.202826017217949,0.0521732085624794,0.100566528435489,0.305085506000408,0.000102093404105123
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20647.Liking for cream,36474,0.118776349614818,0.0519882699733488,0.0168793404670543,0.220673358762581,0.0223583459003506
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20648.Liking for croissant,36474,0.107491754222434,0.0525174094750291,0.00455763165137738,0.210425876793491,0.040712536947839
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20649.Liking for cucumber,36474,0.0498018696385747,0.0521811748245903,-0.0524732330176223,0.152076972294772,0.339909021573315
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20650.Liking for curry,36474,0.0844509914460121,0.0529527694025267,-0.0193364365829403,0.188238419474965,0.110789058289424
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20651.Liking for dairy products,36474,0.133778412348236,0.0529085038152184,0.0300777448704084,0.237479079826065,0.0114749622964658
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20652.Liking for dark chocolate,36474,-0.0827200146710631,0.0530129787678713,-0.186625453056091,0.0211854237139646,0.118712022639807
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20653.Liking for diet fizzy drinks,36474,0.0974730096981133,0.0531271137064667,-0.00665613316656147,0.201602152562788,0.0665859640474467
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20654.Liking for dried fruit,36474,-0.0695767126811938,0.052332884446645,-0.172149166196618,0.0329957408342304,0.183720725608849
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20655.Liking for eggs,36474,0.0903184488971845,0.0535660087236217,-0.0146709282011139,0.195307825995483,0.0918133214582709
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20656.Liking for exercising alone,36474,-0.163486990201834,0.0522612099661078,-0.265918961735405,-0.0610550186682622,0.00176483051080118
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20657.Liking for exercising with others,36474,-0.171197442759611,0.0521865893555199,-0.27348315789643,-0.0689117276227924,0.00104079060601185
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20658.Liking for extra virgin olive oil,36474,-0.0400654277355775,0.0526102811511609,-0.143181578791853,0.0630507233206979,0.446350687007808
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20659.Liking for fatty foods,36474,0.0618135303922018,0.051997644403001,-0.0401018526376802,0.163728913422084,0.234563877283874
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20660.Liking for fresh tomatoes,36474,-0.0136749583988929,0.0541733472503246,-0.119854719009529,0.0925048022117432,0.800715590804147
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20661.Liking for fried chicken,36474,0.138401507535597,0.0525803890932797,0.0353439449127691,0.241459070158425,0.00850024433931477
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20662.Liking for fried or battered fish,36474,0.0873215652974866,0.0531997679633971,-0.0169499799107716,0.191593110505745,0.100756474404022
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20663.Liking for fruit,36474,-0.00912846349977643,0.0549445584394579,-0.116819798041114,0.098562871041561,0.868051410972134
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20664.Liking for garlic,36474,-0.0481428300627147,0.0528592430552662,-0.151746946451036,0.055461286325607,0.362442318161613
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20665.Liking for gherkins,36474,-0.0705636461243622,0.0520294586736251,-0.172541385124667,0.0314140928759431,0.175066561685082
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20666.Liking for globe artichoke,36474,-0.0729372437519398,0.052338109840171,-0.175519939038675,0.0296454515347954,0.163484421664534
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20667.Liking for goat's cheese,36474,-0.0555572050060787,0.0522737593165978,-0.15801377326661,0.0468993632544529,0.287899619296402
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20668.Liking for going to a cafe,36474,0.099494774186388,0.0521623394087545,-0.00274341105477093,0.201732959427547,0.056504384261773
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20669.Liking for going to the gym,36474,-0.202138766882143,0.0518465140225619,-0.303757934366365,-0.100519599397922,9.74776001179934e-05
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20670.Liking for going to the pub,36474,-0.0137786286266572,0.0521478882087713,-0.115988489515849,0.0884312322625347,0.791615645138488
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20671.Liking for grapefruit,36474,-0.0133221074857616,0.0517487012075404,-0.114749561852541,0.0881053468810176,0.79684702814652
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20672.Liking for green olives,36474,-0.0723067708845147,0.0523168517730368,-0.174847800359667,0.0302342585906374,0.166982301616257
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20673.Liking for haddock,36474,-0.0368629801411937,0.0539176687381484,-0.142541610867964,0.0688156505855772,0.494190972888317
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20674.Liking for ham,36474,0.16024965927177,0.0530363230767244,0.0562984660413897,0.264200852502149,0.00252328179813442
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20675.Liking for hard cheese,36474,0.0336593752327348,0.0531171168605235,-0.0704501738138913,0.137768924279361,0.526306624593214
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20676.Liking for herring,36474,-0.132137372664169,0.0522365270114598,-0.234520965606631,-0.029753779721708,0.0114387201065949
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20677.Liking for honey,36474,0.00398861798264567,0.0521286894459766,-0.0981836133314685,0.10616084929676,0.939011459494456
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20678.Liking for horseradish or wasabi,36474,-0.0290020771399837,0.0520244243505897,-0.13096994886714,0.0729657945871722,0.577221935909911
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20679.Liking for ice cream,36474,0.065215382587521,0.0529212440783752,-0.0385102558060944,0.168941020981136,0.217870112590251
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20680.Liking for jam,36474,0.125901236691233,0.0522469779459069,0.0234971599172552,0.22830531346521,0.0159870416272756
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20681.Liking for kiwi fruit,36474,-0.0893846764854227,0.0523531685278453,-0.191996886799999,0.013227533829154,0.0877982806279462
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20682.Liking for lager,36474,-0.00530517259934085,0.0525531815036681,-0.10830940834653,0.0976990631478487,0.919593798277433
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20683.Liking for lamb,36474,-0.00277860439328468,0.0527734807095561,-0.106214626584015,0.100657417797445,0.958010897695283
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20684.Liking for lemons,36474,-0.0059184160645441,0.0523933513894476,-0.108609384787861,0.0967725526587732,0.910064195824843
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20685.Liking for lentils or beans,36474,-0.0502504805496193,0.0527577061838463,-0.153655584669958,0.0531546235707195,0.34088459836823
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20686.Liking for liver,36474,-0.0722114665998494,0.0523733321069484,-0.174863197529468,0.0304402643297695,0.168000841944887
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20687.Liking for mackerel,36474,-0.186600722323199,0.0528022437010853,-0.290093119977326,-0.0831083246690714,0.000411742933158691
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20688.Liking for marzipan,36474,-0.0103068956272457,0.0520490992732002,-0.112323130202718,0.0917093389482266,0.843032534498883
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20689.Liking for mayonnaise,36474,0.0989481258478183,0.0523083980341432,-0.00357633429910235,0.201472585994739,0.0585770238411452
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20690.Liking for melon,36474,0.0987745855955487,0.0528510640741219,-0.00481349998973037,0.202362671180828,0.061670624647554
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20691.Liking for milk chocolate,36474,0.143678752228252,0.0521712090281166,0.0414231825331432,0.24593432192336,0.00590096328533835
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20692.Liking for mushrooms,36474,-0.00524037789273405,0.0536805040738799,-0.110454165877539,0.0999734100920706,0.922235241953702
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20694.Liking for orange juice,36474,0.129714446804836,0.0528497042088202,0.0261290265555486,0.233299867054124,0.014133406341324
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20695.Liking for oranges,36474,0.0495298650577184,0.0531922389706585,-0.0547269233247722,0.153786653440209,0.351805416041828
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20696.Liking for pasta,36474,0.034337175752108,0.052733638795523,-0.069020756287117,0.137695107791333,0.514972764024643
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20697.Liking for pears,36474,0.000360534441842977,0.0531714193850199,-0.103855447552796,0.104576516436482,0.994590072638217
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20698.Liking for pizza,36474,0.117375697972146,0.0528472819394161,0.0137950253708902,0.220956370573401,0.026376917675287
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20699.Liking for plain yogurt,36474,-0.069474955468067,0.0524302885052883,-0.172238320938432,0.0332884100022981,0.185179135344703
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20700.Liking for plums,36474,-0.0426935425098463,0.05313241906781,-0.146833083882754,0.0614459988630613,0.421692205877274
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20701.Liking for pollock,36474,-0.0666836945204617,0.052056081671347,-0.168713614596302,0.0353462255553784,0.200232421910556
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20702.Liking for pork chop,36474,0.0280948080624743,0.0525455837726036,-0.0748945361318288,0.131084152256777,0.592889751408834
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20703.Liking for porridge,36474,-0.100991152994795,0.0527067546749047,-0.204296392157608,0.00231408616801868,0.0553892048992857
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20704.Liking for potato crisps,36474,0.0953483279241215,0.0527340594298537,-0.00801042855839183,0.198707084406635,0.0706294885951286
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20705.Liking for potatoes,36474,0.220117176574922,0.0534498793241672,0.115355413099555,0.32487894005029,3.85755379586208e-05
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20706.Liking for prawns,36474,-0.0362736059954775,0.0533109802653685,-0.1407631273156,0.0682159153246448,0.496261571971758
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20707.Liking for raw carrots,36474,-0.0279787414659039,0.0523733953166065,-0.130630596286453,0.0746731133546449,0.593206728022666
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20708.Liking for red meat,36474,0.089187508011259,0.0525795613776833,-0.0138684322890002,0.192243448311518,0.0898801815468638
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20709.Liking for red wine,36474,-0.0637223585175148,0.0534102061753729,-0.168406362621246,0.0409616455862161,0.232876160765651
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20710.Liking for regular (non-diet) fizzy drinks,36474,0.108226902157445,0.0523434404403531,0.00563375889435305,0.210820045420537,0.0387073953377772
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20711.Liking for roast chicken,36474,0.0305850761862114,0.0543153149689453,-0.0758729411529213,0.137043093525344,0.573381309618293
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20712.Liking for salad dressing,36474,0.0775268887056362,0.051923298949376,-0.0242427772351407,0.179296554646413,0.135450061053245
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20713.Liking for salad leaves,36474,-2.82182181525087e-05,0.0524801347792997,-0.10288928238558,0.102832845949275,0.999570996455108
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20714.Liking for salami,36474,0.035011775949786,0.0521814125500451,-0.0672637926483025,0.137287344547874,0.502264062088738
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20715.Liking for salmon,36474,-0.19540613160243,0.0537784014439565,-0.300811798432585,-0.0900004647722753,0.000281337744656646
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20716.Liking for salty foods,36474,0.0497478585290818,0.0520060926532763,-0.0521840830713397,0.151679800129503,0.338809947067098
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20717.Liking for salty pretzels,36474,0.0875960706002941,0.0524625010364178,-0.0152304314310848,0.190422572631673,0.0950206698050045
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20718.Liking for sardines,36474,-0.178691094508648,0.052644067976691,-0.281873467742963,-0.0755087212743339,0.000691378443943401
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20719.Liking for sausages (meat),36474,0.162505713341622,0.0530135621997012,0.0585991314302074,0.266412295253036,0.00218144430080923
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20720.Liking for savoury biscuits,36474,0.0508605391018949,0.0527629836789425,-0.0525549089088324,0.154275987112622,0.335103852028171
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20721.Liking for shellfish (other than prawns),36474,-0.0263483197062768,0.0523167949801841,-0.128889237867438,0.0761925984548841,0.614535347614184
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20722.Liking for skimmed milk,36474,-0.0267314196533366,0.0521932213078588,-0.12903013341674,0.0755672941100667,0.608551546714483
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20723.Liking for smoked fish,36474,-0.114139392778095,0.0528802425368052,-0.217784668150234,-0.010494117405957,0.0309229734353699
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20724.Liking for soft cheese,36474,-0.0228381776485917,0.0522941727254032,-0.125334756190382,0.0796584008931987,0.66232271500353
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20725.Liking for soy sauce,36474,0.0828583216054409,0.0527005730948276,-0.0204348016604211,0.186151444871303,0.115933487524598
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20726.Liking for soya milk,36474,-0.112634446469489,0.052297844785113,-0.21513822224831,-0.0101306706906673,0.0312931321047973
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20727.Liking for spicy foods,36474,0.0246864573083691,0.0524247860732652,-0.0780661233952307,0.127439038011969,0.637730308398747
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20728.Liking for spinach,36474,-0.136501706573545,0.0527354933348884,-0.239863273509927,-0.0331401396371639,0.00965942222076128
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20729.Liking for spirits,36474,0.016824809009454,0.0522321637010126,-0.0855502318445306,0.119199849863439,0.747373474807904
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20730.Liking for strawberries,36474,0.0512608640267175,0.0543389150181763,-0.055243409408908,0.157765137462343,0.345528546430489
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20731.Liking for sweet coffee house drinks,36474,0.233159763842411,0.0526084194029594,0.13004726181261,0.336272265872211,9.46352445968137e-06
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20732.Liking for sweet foods,36474,0.0913277750894779,0.0525701000842294,-0.0117096210756118,0.194365171254567,0.0823809624046485
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20733.Liking for taking the stairs,36474,-0.12995316448153,0.053209092518675,-0.234242985818133,-0.0256633431449272,0.0146154245188021
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20734.Liking for tea with sugar,36474,0.154968082099184,0.0575866251060314,0.0420982968913623,0.267837867307006,0.00713796152517843
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20735.Liking for tea without sugar,36474,-0.23039400194393,0.0537203140493339,-0.335685817480624,-0.125102186407236,1.81814111637074e-05
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20736.Liking for tomato ketchup,36474,0.107508265415368,0.0522974822325293,0.00500520023961067,0.210011330591125,0.0398437686846283
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20737.Liking for tinned tuna,36474,-0.150840949618277,0.0527803907877627,-0.254290515562292,-0.047391383674262,0.00427578000186178
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20738.Liking for turnip (white),36474,-0.101722590454699,0.0521280950206812,-0.203893656695234,0.000448475785835914,0.0510453290431278
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20739.Liking for vegetables,36474,-0.0827948432828238,0.0544761122717688,-0.189568023335491,0.023978336769843,0.12859199566422
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20740.Liking for vinegar,36474,0.0112588786844754,0.0527192577431568,-0.0920708664921119,0.114588623861063,0.830893452504901
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20741.Liking for watching television,36474,0.136274285349152,0.0529625943611878,0.0324676004012241,0.24008097029708,0.0100994406139744
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20742.Liking for whisky,36474,-0.0618783661152162,0.0526714886628863,-0.165114483894473,0.041357751664041,0.240111056789115
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20743.Liking for white bread,36474,0.195223965548571,0.0519919761876662,0.0933196922207448,0.297128238876396,0.000174670912259991
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20744.Liking for white rice,36474,0.179337814244159,0.0526807179181881,0.0760836071245107,0.282592021363808,0.000666798113578304
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20745.Liking for white wine,36474,-0.0108893383953897,0.052411316688373,-0.113615519104601,0.0918368423138214,0.835416334084955
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20746.Liking for whole grain breakfast cereal,36474,-0.100591789809711,0.052906869306652,-0.204289253650749,0.00310567403132722,0.0572993422659899
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20747.Liking for whole milk,36474,0.175777954124358,0.0516985010664815,0.0744488920340539,0.277107016214661,0.000677063002773617
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20748.Liking for wholemeal bread,36474,-0.0784089332131882,0.0538305860780415,-0.18391688192615,0.0270990154997731,0.145270330504413
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20749.Liking for working up a sweat,36474,-0.267499295529547,0.0522936255364356,-0.36999480158096,-0.165003789478133,3.2058804982347e-07
PON2,Serum paraoxonase/arylesterase 2,Physical measures,X21001.Body mass index (BMI),51743,0.0369871703470893,0.0138310913267485,0.00987823134666223,0.0640961093475164,0.00749593068928028
PON2,Serum paraoxonase/arylesterase 2,Physical measures,X21002.Weight,51774,-0.0172316213656936,0.00662253317843299,-0.0302117863954223,-0.00425145633596497,0.00927493776170684
PON2,Serum paraoxonase/arylesterase 2,Physical measures,X21021.Pulse wave Arterial Stiffness index,36366,0.0270959755959651,0.00498979664813136,0.0173159741656276,0.0368759770263025,5.79682491555345e-08
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X21025.Frequency of discomfort or pain in abdomen in last 3 months,36231,0.108338283072463,0.0576323184009777,-0.0046210609934537,0.221297627138379,0.0601709459616007
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X21033.Frequency of hard or lumpy stools in the last 3 months,36233,-0.00782447039759151,0.0583133247006092,-0.122118586810785,0.106469646015602,0.893263935619243
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X21034.Frequency of loose or mushy or watery stools in the last 3 months,36234,-0.028260156595372,0.0567297788971712,-0.139450523233828,0.0829302100430836,0.618389978311908
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X21040.Satisfaction with bowel habits,36207,0.0505509405710881,0.0526128021992963,-0.0525701517395326,0.153672032881709,0.336677958191443
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X21041.Degree to which abdominal pain or discomfort or altered bowel habits affect or interfere with life in general,36207,0.021171500230026,0.0574439150847657,-0.0914185733361149,0.133761573796167,0.712466361224724
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X21042.Greatest number of times bowels opened per day,36203,0.0120560453534426,0.056576319703285,-0.098833541264996,0.122945631971881,0.831259757147739
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X21043.Least number of times bowels opened per week,36169,0.0339725139054516,0.0570366398627648,-0.0778193002255673,0.145764328036471,0.551442817952606
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X21044.Average number of times bowels opened per day,36178,0.0320833580900042,0.062243475672788,-0.0899138542286603,0.154080570408669,0.606254117782748
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X21048.Degree bothered by back pain in the past 3 months,36240,-0.0127984920416183,0.057010661768847,-0.124539389108559,0.0989424050253219,0.82237975068174
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X21049.Degree bothered by pain in arms or legs or joints in the past 3 months,36236,-0.0405387108992805,0.0573111974385003,-0.152868657878741,0.0717912360801802,0.479374542262455
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X21051.Degree bothered by headaches in the last 3 months,36238,-0.192761997278349,0.0662305012307179,-0.322573779690556,-0.0629502148661415,0.00361926502236143
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X21052.Degree bothered by chest pain in the last 3 months,36238,-0.160635567659157,0.0826639888593412,-0.322656985823466,0.00138585050515144,0.0520244488319163
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X21053.Degree bothered by dizziness in the last 3 months,36238,-0.0859915821727311,0.0697393592953324,-0.222680726391583,0.0506975620461204,0.217597923570086
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X21054.Degree bothered by fainting spells in the last 3 months,36237,-0.175861457396192,0.166794250234711,-0.502778187856226,0.151055273063843,0.291750742182983
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X21055.Degree bothered by feeling heart pound or race in the last 3 months,36240,-0.0240501753262639,0.0708219382962671,-0.162861174386947,0.11476082373442,0.734177269165446
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X21056.Degree bothered by shortness of breath in the last 3 months,36237,-0.112523721692944,0.0646815677693703,-0.23929959452091,0.0142521511350216,0.0819596117039205
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X21057.Degree bothered by pain or problems during intercourse in the last 3 months,36101,0.0756293542607219,0.0646045486483542,-0.0509955610900524,0.202254269611496,0.24177644450084
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X21058.Degree bothered by urinary frequency or bladder irritability in the last 3 months,36235,0.0224487743357803,0.0583072484471797,-0.0918334326206919,0.136730981292253,0.700241995385888
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X21059.Degree bothered by nausea in the last 3 months,36239,-0.0664372864064154,0.0991739459437434,-0.260818220456152,0.127943647643322,0.502937548379729
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X21060.Degree bothered by feeling tired all the time in the last 3 months,36240,-0.1822970895331,0.0573479490002805,-0.29469906957365,-0.0698951094925507,0.00148481235403477
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X21061.Degree bothered by trouble sleeping in the last 3 months,36239,-0.0518279646243876,0.0573346322479625,-0.164203843830394,0.0605479145816189,0.366047428948939
PON2,Serum paraoxonase/arylesterase 2,Working and living environment,X21100.Water hardness (USGS classification),51614,-0.0161342387418847,0.0316257767509763,-0.0781207611737983,0.0458522836900289,0.609943546648005
PON2,Serum paraoxonase/arylesterase 2,Lifestyle factors,X2139.Age first had sexual intercourse,48827,-0.00429507345163533,0.00270010826931025,-0.00958728565948342,0.000997138756212764,0.111691798391491
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X2149.Lifetime number of sexual partners,47169,-0.0260548687190431,0.036535189129428,-0.0976638394127219,0.0455541019746357,0.475765315554376
PON2,Serum paraoxonase/arylesterase 2,Physical activities,X22032.IPAQ activity group,48058,-0.192087815364389,0.034537951744515,-0.259782200783638,-0.124393429945139,2.70758338381686e-08
PON2,Serum paraoxonase/arylesterase 2,Physical activities,X22033.Summed days activity,48457,-0.0154465700825236,0.00268964739033643,-0.020718278967583,-0.0101748611974642,9.43877640251705e-09
PON2,Serum paraoxonase/arylesterase 2,Physical activities,X22034.Summed minutes activity,48058,-0.00679924485096829,0.00271647245530637,-0.0121235308633688,-0.0014749588385678,0.0123237828380445
PON2,Serum paraoxonase/arylesterase 2,Physical activities,X22037.MET minutes per week for walking,47350,-0.00164703635689055,0.00277238832779106,-0.00708091747936103,0.00378684476557994,0.552461938916354
PON2,Serum paraoxonase/arylesterase 2,Physical activities,X22038.MET minutes per week for moderate activity,48058,-0.00569095087990574,0.00275788057638691,-0.0110963968096241,-0.000285504950187393,0.0390761657205545
PON2,Serum paraoxonase/arylesterase 2,Physical activities,X22039.MET minutes per week for vigorous activity,48058,-0.264965429804522,0.0344712084040659,-0.332528998276492,-0.197401861332553,1.5828615878312e-14
PON2,Serum paraoxonase/arylesterase 2,Physical activities,X22040.Summed MET minutes per week for all activity,47350,-0.0109234064994346,0.00274627187936793,-0.0163060993829957,-0.00554071361587343,6.98933835720661e-05
PON2,Serum paraoxonase/arylesterase 2,Eye measures,X2217.Age started wearing glasses or contact lenses,48095,0.00609577314328384,0.00282515193389109,0.000558475352857296,0.0116330709337104,0.0309649144671562
PON2,Serum paraoxonase/arylesterase 2,Working and living environment,X22501.Year ended full time education,34068,0.00336568327231684,0.0124965565836876,-0.0211275676317108,0.0278589341763445,0.787686791569265
PON2,Serum paraoxonase/arylesterase 2,Lifestyle factors,X22506.Tobacco smoking,34031,0.140445983339425,0.127910939445097,-0.110259457972965,0.391151424651815,0.272253962134908
PON2,Serum paraoxonase/arylesterase 2,Lifestyle factors,X2277.Frequency of solarium or sunlamp use,50426,-0.0490945366193344,0.097626572117869,-0.240442617970358,0.142253544731689,0.615053098159538
PON2,Serum paraoxonase/arylesterase 2,Physical measures,X23098.Weight,51338,-0.0175212927584958,0.00668047139219196,-0.0306150166871921,-0.00442756882979958,0.00872781056389872
PON2,Serum paraoxonase/arylesterase 2,Physical measures,X23099.Body fat percentage,51307,0.0756234225625139,0.00594520042583868,0.0639708297278701,0.0872760153971578,6.11523497757718e-37
PON2,Serum paraoxonase/arylesterase 2,Physical measures,X23100.Whole body fat mass,51268,0.0588180422860275,0.00594987239033528,0.0471562924009704,0.0704797921710847,5.35083446067178e-23
PON2,Serum paraoxonase/arylesterase 2,Physical measures,X23101.Whole body fat-free mass,51332,-0.045567537875921,0.00574721376556942,-0.0568320768564371,-0.034302998895405,2.31715693073832e-15
PON2,Serum paraoxonase/arylesterase 2,Physical measures,X23102.Whole body water mass,51338,-0.0456507642237865,0.00573384766559762,-0.0568891056483579,-0.0344124227992152,1.7768961596194e-15
PON2,Serum paraoxonase/arylesterase 2,Physical measures,X23104.Body mass index (BMI),51338,0.0331625328090297,0.0136383493638563,0.00643136805587137,0.059893697562188,0.015041421208775
PON2,Serum paraoxonase/arylesterase 2,Physical measures,X23105.Basal metabolic rate,51338,-0.0449878441578729,0.00597484226414045,-0.0566985349955882,-0.0332771533201576,5.28110994384821e-14
PON2,Serum paraoxonase/arylesterase 2,Physical measures,X23106.Impedance of whole body,51338,0.0573217034753438,0.00470166588789838,0.048106438335063,0.0665369686156246,4.39299442436668e-34
PON2,Serum paraoxonase/arylesterase 2,Physical measures,X23107.Impedance of leg (right),51338,0.0506231368787248,0.00380305358185822,0.0431691518582827,0.0580771218991669,2.82056858796062e-40
PON2,Serum paraoxonase/arylesterase 2,Physical measures,X23108.Impedance of leg (left),51338,0.0502081314847479,0.00379247498370621,0.0427748805166837,0.0576413824528121,7.34978847212988e-40
PON2,Serum paraoxonase/arylesterase 2,Physical measures,X23109.Impedance of arm (right),51338,0.0269533292514766,0.0046671521578134,0.0178057110221623,0.0361009474807908,7.79033794036607e-09
PON2,Serum paraoxonase/arylesterase 2,Physical measures,X23110.Impedance of arm (left),51338,0.0322185551961997,0.00465773910222627,0.0230893865558362,0.0413477238365632,4.72845571763721e-12
PON2,Serum paraoxonase/arylesterase 2,Physical measures,X23111.Leg fat percentage (right),51338,0.0758716777499954,0.00605392848504256,0.0640059779193119,0.0877373775806788,6.50535056452275e-36
PON2,Serum paraoxonase/arylesterase 2,Physical measures,X23112.Leg fat mass (right),51338,0.0698135468227021,0.00653226779724799,0.057010301940096,0.0826167917053081,1.34718612684522e-26
PON2,Serum paraoxonase/arylesterase 2,Physical measures,X23113.Leg fat-free mass (right),51337,-0.0583019169911416,0.00631647136395087,-0.0706822008644853,-0.0459216331177979,2.93218360322658e-20
PON2,Serum paraoxonase/arylesterase 2,Physical measures,X23114.Leg predicted mass (right),51337,-0.0586075132132794,0.00636209480749107,-0.0710772190359619,-0.0461378073905969,3.47107892066269e-20
PON2,Serum paraoxonase/arylesterase 2,Physical measures,X23115.Leg fat percentage (left),51337,0.0784729477299833,0.00634219996798678,0.0660422357927292,0.0909036596672374,4.73649066224463e-35
PON2,Serum paraoxonase/arylesterase 2,Physical measures,X23116.Leg fat mass (left),51337,0.0689188579568496,0.00692308861299922,0.0553496042753711,0.0824881116383281,2.67855240038773e-23
PON2,Serum paraoxonase/arylesterase 2,Physical measures,X23117.Leg fat-free mass (left),51336,-0.0559665915450317,0.00687592911993699,-0.0694434126201082,-0.0424897704699552,4.17119835959167e-16
PON2,Serum paraoxonase/arylesterase 2,Physical measures,X23118.Leg predicted mass (left),51336,-0.0560983711437199,0.00692997900052464,-0.0696811299847482,-0.0425156123026916,6.00998604937045e-16
PON2,Serum paraoxonase/arylesterase 2,Physical measures,X23119.Arm fat percentage (right),51336,0.046362847482427,0.00669478372543173,0.0332410713805808,0.0594846235842732,4.46899677558913e-12
PON2,Serum paraoxonase/arylesterase 2,Physical measures,X23120.Arm fat mass (right),51335,0.0226327527582339,0.00733119802747824,0.00826360462437656,0.0370019008920913,0.00202305996040933
PON2,Serum paraoxonase/arylesterase 2,Physical measures,X23121.Arm fat-free mass (right),51334,-0.0320029693287097,0.00631233943781945,-0.0443751546268358,-0.0196307840305836,4.01134960961778e-07
PON2,Serum paraoxonase/arylesterase 2,Physical measures,X23122.Arm predicted mass (right),51334,-0.032590290187895,0.0063401340863147,-0.0450169529970718,-0.0201636273787182,2.7654786296888e-07
PON2,Serum paraoxonase/arylesterase 2,Physical measures,X23123.Arm fat percentage (left),51332,0.0496339714841241,0.00629729074195588,0.0372912816298906,0.0619766613383576,3.3712599612656e-15
PON2,Serum paraoxonase/arylesterase 2,Physical measures,X23124.Arm fat mass (left),51332,0.0299566902925383,0.0070421798332059,0.0161540178194547,0.0437593627656219,2.10924108508928e-05
PON2,Serum paraoxonase/arylesterase 2,Physical measures,X23125.Arm fat-free mass (left),51328,-0.0339834068409566,0.00574817596090672,-0.0452498317243337,-0.0227169819575794,3.42737366591974e-09
PON2,Serum paraoxonase/arylesterase 2,Physical measures,X23126.Arm predicted mass (left),51327,-0.0335248791830504,0.0057806524019168,-0.0448549578908073,-0.0221948004752934,6.73951887202923e-09
PON2,Serum paraoxonase/arylesterase 2,Physical measures,X23127.Trunk fat percentage,51325,0.0559426983585187,0.00503104234495195,0.0460818553624129,0.0658035413546245,1.1954774653889e-28
PON2,Serum paraoxonase/arylesterase 2,Physical measures,X23128.Trunk fat mass,51325,0.046440412507013,0.00531144640495316,0.0360299775533048,0.0568508474607212,2.41461536438529e-18
PON2,Serum paraoxonase/arylesterase 2,Physical measures,X23129.Trunk fat-free mass,51324,-0.0366882082712248,0.0049826687894645,-0.0464542390985753,-0.0269221774438744,1.85713995074182e-13
PON2,Serum paraoxonase/arylesterase 2,Physical measures,X23130.Trunk predicted mass,51322,-0.036943541035162,0.00497845646685225,-0.0467013157101924,-0.0271857663601315,1.20610270504843e-13
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23400.Total Cholesterol,41900,0.0284257289680237,0.00353120517896656,0.0215045668172492,0.0353468911187981,8.98856235861615e-16
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23401.Total Cholesterol Minus HDL-C,41900,0.0365275362698537,0.00344604425192981,0.0297732895360712,0.0432817830036361,3.79492500885674e-26
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,"X23402.Remnant Cholesterol (Non-HDL, Non-LDL -Cholesterol)",41900,0.0393318853612405,0.00346319062134972,0.032544031743395,0.0461197389790859,9.37175511159521e-30
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23403.VLDL Cholesterol,41900,0.0492499347160138,0.00356372560029217,0.0422650325394412,0.0562348368925865,3.84614328416875e-43
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23404.Clinical LDL Cholesterol,41900,0.0283569150767511,0.00344362722234516,0.0216074057209546,0.0351064244325476,1.96850688947136e-16
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23405.LDL Cholesterol,41900,0.0329637011525401,0.00342492470370572,0.0262508487332769,0.0396765535718033,7.41346504895311e-22
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23406.HDL Cholesterol,41900,-0.0222416920923273,0.00390808872025832,-0.0299015459840336,-0.014581838200621,1.2881682151309e-08
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23407.Total Triglycerides,41900,0.0566893817641811,0.00361137779350636,0.0496110812889086,0.0637676822394535,4.90692805168886e-55
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23408.Triglycerides in VLDL,41900,0.0537978955475129,0.00366982465498306,0.0466050392237461,0.0609907518712797,2.78593259153922e-48
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23409.Triglycerides in LDL,41900,0.061441730907019,0.00339579250972438,0.0547859775879592,0.0680974842260788,2.63484977359e-72
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23410.Triglycerides in HDL,41900,0.053886197536905,0.0035339773050776,0.0469596020189529,0.0608127930548571,4.67284635876911e-52
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23411.Total Phospholipids in Lipoprotein Particles,41900,0.0361359481001568,0.00354327754737185,0.0291911241073079,0.0430807720930056,2.47581140355776e-24
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23412.Phospholipids in VLDL,41900,0.0561559522390496,0.00359387419335973,0.0491119588200645,0.0631999456580346,1.49086128132123e-54
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23413.Phospholipids in LDL,41900,0.0348420487897495,0.00343618884943303,0.0281071186448607,0.0415769789346382,4.50269410744238e-24
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23414.Phospholipids in HDL,41900,-0.00170630693531191,0.00374904602214871,-0.00905443713872338,0.00564182326809957,0.649022451092079
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23415.Total Esterified Cholesterol,41900,0.0264463208898966,0.00355097681542857,0.0194864063316566,0.0334062354481366,1.00890315434739e-13
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23416.Cholesteryl Esters in VLDL,41900,0.0445549080251186,0.00354808221235832,0.0376006668888963,0.0515091491613409,5.78579894172663e-36
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23417.Cholesteryl Esters in LDL,41900,0.0363186606814861,0.00342214987707539,0.0296112469224183,0.0430260744405538,3.30690772986131e-26
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23418.Cholesteryl Esters in HDL,41900,-0.0268547120019949,0.00390860918577554,-0.0345155860061149,-0.0191938379978748,6.67512368876999e-12
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23419.Total Free Cholesterol,41900,0.0328551418004241,0.00348559093200551,0.0260233835736933,0.0396869000271549,4.95539714586176e-21
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23420.Free Cholesterol in VLDL,41900,0.0535102825829281,0.0035833674909904,0.046486882300587,0.0605336828652693,5.11148689102476e-50
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23421.Free Cholesterol in LDL,41900,0.0227932166021646,0.00344723977742957,0.0160366266384026,0.0295498065659265,3.9358837460535e-11
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23422.Free Cholesterol in HDL,41900,-0.00527201266868038,0.00389205966150787,-0.0129004496052358,0.00235642426787504,0.17558207814089
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23423.Total Lipids in Lipoprotein Particles,41900,0.0436983006464685,0.00339870599534134,0.0370368368955995,0.0503597643973375,1.31006238913941e-37
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23424.Total Lipids in VLDL,41900,0.0560021600135579,0.00359679155490327,0.0489524485659475,0.0630518714611683,3.49697359991962e-54
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23425.Total Lipids in LDL,41900,0.0366033291782756,0.00342303631022771,0.0298941780102293,0.0433124803463219,1.40389290982797e-26
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23426.Total Lipids in HDL,41900,-0.00592944006414505,0.00380933381837175,-0.0133957343481537,0.00153685421986358,0.11959981478901
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23427.Total Concentration of Lipoprotein Particles,41900,0.0136445435587572,0.00361062814702444,0.00656771239058934,0.0207213747269252,0.000158150282682017
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23428.Concentration of VLDL Particles,41900,0.0531170973831421,0.00355152114084786,0.0461561159470803,0.0600780788192039,3.6294225090154e-50
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23429.Concentration of LDL Particles,41900,0.0361549359871877,0.00344096592737096,0.0294106427695406,0.0428992292048348,1.00923460103786e-25
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23430.Concentration of HDL Particles,41900,0.00738376682518906,0.00361400011279323,0.000300326604114334,0.0144672070462638,0.0410621202600222
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23431.Average Diameter for VLDL Particles,41900,0.0428627455343919,0.00373849592457913,0.0355352935222168,0.050190197546567,2.73658726238694e-30
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23432.Average Diameter for LDL Particles,41900,-0.0249915019422375,0.00354741959285848,-0.0319444443442402,-0.0180385595402349,1.94614638006593e-12
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23433.Average Diameter for HDL Particles,41900,-0.0372477345537007,0.00391529612019128,-0.0449217149492756,-0.0295737541581258,2.15846732673709e-21
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23434.Phosphoglycerides,41891,0.032650817368717,0.0035514465719814,0.0256899820876334,0.0396116526498005,4.3540435836656e-20
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23435.Triglycerides to Phosphoglycerides ratio,41891,0.0527147023658109,0.00381606356275538,0.0452352177828104,0.0601941869488115,4.17127932454199e-43
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23436.Total Cholines,41891,0.03101047828466,0.00361324909553231,0.0239285100574167,0.0380924465119033,1.03108904142442e-17
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23437.Phosphatidylcholines,41891,0.0305976519185391,0.00362612903886015,0.0234904390023732,0.037704864834705,3.55620694619625e-17
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23438.Sphingomyelins,41891,0.0220644322054347,0.00365178440109322,0.014906934779292,0.0292219296315774,1.5619113055e-09
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23439.Apolipoprotein B,41900,0.0383214872484873,0.00345162131092539,0.0315563094790736,0.0450866650179011,1.62841849068341e-28
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23440.Apolipoprotein A1,41900,0.00188667887192397,0.00372552227104414,-0.00541534477932255,0.00918870252317049,0.612570253745175
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23441.Apolipoprotein B to Apolipoprotein A1 ratio,41900,0.0339645407426317,0.00352744183649455,0.0270507547431024,0.040878326742161,7.13169352182478e-22
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23442.Total Fatty Acids,41891,0.0471031927514566,0.00330662272308381,0.0406222122142123,0.0535841732887009,1.04292828874503e-45
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23443.Degree of Unsaturation,41891,-0.0775287933246305,0.00355028375375145,-0.0844873494819834,-0.0705702371672777,6.80588936453319e-104
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23444.Omega-3 Fatty Acids,41891,-0.0267106109685631,0.00349525064190829,-0.0335613022267033,-0.0198599197104228,2.2854487157078e-14
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23445.Omega-6 Fatty Acids,41891,0.0327158528851063,0.0034363497228765,0.0259806074282684,0.0394510983419442,2.01641662660996e-21
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23446.Polyunsaturated Fatty Acids,41891,0.021394460934662,0.00345750916635615,0.0146177429686039,0.02817117890072,6.27915943293207e-10
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23447.Monounsaturated Fatty Acids,41891,0.0564693902774494,0.00336078096673353,0.0498822595826517,0.0630565209722471,1.03763761837604e-62
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23448.Saturated Fatty Acids,41891,0.0531364527405485,0.00325542686896879,0.0467558160773697,0.0595170894037274,2.57843190234975e-59
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23449.Linoleic Acid,41891,0.0352644623918244,0.0034285102657487,0.0285445822709569,0.0419843425126918,1.0123871274195e-24
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23450.Docosahexaenoic Acid,41891,-0.042737550998814,0.00345873113823117,-0.0495166640297471,-0.0359584379678809,6.9887143427247e-35
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23451.Omega-3 Fatty Acids to Total Fatty Acids percentage,41891,-0.0626500758051472,0.00347675764612562,-0.0694645207915534,-0.055835630818741,9.72646352467972e-72
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23452.Omega-6 Fatty Acids to Total Fatty Acids percentage,41891,-0.0462724114101876,0.0034267760562493,-0.0529888924804363,-0.039555930339939,2.80181648327138e-41
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23453.Polyunsaturated Fatty Acids to Total Fatty Acids percentage,41891,-0.0711059019568849,0.0034808801775999,-0.0779284271049807,-0.0642833768087891,2.38988105704723e-91
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23454.Monounsaturated Fatty Acids to Total Fatty Acids percentage,41891,0.0627581337357745,0.00367125827369512,0.0555624675193321,0.069953799952217,8.03592032873494e-65
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23455.Saturated Fatty Acids to Total Fatty Acids percentage,41891,0.0493755559045057,0.00318737853019528,0.043128293985323,0.0556228178236885,1.17484561639513e-53
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23456.Linoleic Acid to Total Fatty Acids percentage,41891,-0.0207466723927304,0.00353073356943154,-0.0276669101888162,-0.0138264345966446,4.30304039916663e-09
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23457.Docosahexaenoic Acid to Total Fatty Acids percentage,41891,-0.0707385880013429,0.00339359010325637,-0.0773900246037254,-0.0640871513989604,5.58435682272126e-95
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23458.Polyunsaturated Fatty Acids to Monounsaturated Fatty Acids ratio,41891,-0.0702437425937163,0.00362679154555525,-0.0773522540230046,-0.063135231164428,1.95796238186654e-82
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23459.Omega-6 Fatty Acids to Omega-3 Fatty Acids ratio,41891,0.0435870149785827,0.003452229166686,0.0368206458118782,0.0503533841452873,2.46106192289124e-36
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23460.Alanine,41897,0.00776390749826363,0.00346425156720628,0.00097397442653932,0.0145538405699879,0.025032792958615
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23461.Glutamine,41856,-0.0212372197703452,0.00339707671293415,-0.0278954901276961,-0.0145789494129943,4.1868472478713e-10
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23462.Glycine,41886,-0.0161049469210037,0.0041178089044104,-0.0241758523736481,-0.00803404146835935,9.23537959937919e-05
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23463.Histidine,41883,-0.00364778469960945,0.00342889688265485,-0.010368422589613,0.00307285319039405,0.287422238781934
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23464.Total Concentration of Branched-Chain Amino Acids (Leucine + Isoleucine + Valine),41891,0.0168319094174742,0.00384128040851566,0.00930299981678349,0.0243608190181649,1.18578604951249e-05
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23465.Isoleucine,41898,0.00945537003765064,0.00370757649469832,0.00218852010804193,0.0167222199672594,0.0107746554964156
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23466.Leucine,41898,0.0160917060963844,0.00381113880874675,0.00862187403124075,0.023561538161528,2.43448270537475e-05
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23467.Valine,41891,0.0182662063578049,0.00381456179377717,0.0107896652420017,0.0257427474736082,1.69805387703766e-06
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23468.Phenylalanine,41892,0.00544969253196279,0.00352930108090198,-0.00146773758660509,0.0123671226505307,0.122581139050045
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23469.Tyrosine,41886,0.0188370018912194,0.00364589654174173,0.0116910446694056,0.0259829591130332,2.41803388424149e-07
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23470.Glucose,41878,0.000186767008326138,0.00333282889285404,-0.00634557762166778,0.00671911163832005,0.95531191385957
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23471.Lactate,41879,0.0341620991784058,0.0035074597644544,0.0272874780400752,0.0410367203167364,2.42176617525184e-22
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23472.Pyruvate,41854,0.00454509200671502,0.00336911175775154,-0.00205836703847799,0.011148551051908,0.17734473542139
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23473.Citrate,41897,0.013685289271481,0.0034988783266491,0.00682748775124876,0.0205430907917132,9.22432862639219e-05
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23474.3-Hydroxybutyrate,41626,0.0234991345249111,0.00384595681191377,0.0159610591735601,0.031037209876262,1.02415422859364e-09
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23475.Acetate,41888,-0.0211097886320488,0.0033214463527901,-0.0276198234835174,-0.0145997537805802,2.14393491707176e-10
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23476.Acetoacetate,41899,0.00286908856081341,0.00350091717520401,-0.00399270910258644,0.00973088622421326,0.412501726430322
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23477.Acetone,41899,-0.00841554736565605,0.00347895649641355,-0.0152343020986266,-0.00159679263268548,0.0155771678727986
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23478.Creatinine,41642,0.0013962121663008,0.00418747618244019,-0.00681124115128197,0.00960366548388356,0.73881832824724
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23479.Albumin,41898,-0.00162834721141106,0.00345753577692033,-0.0084051173341749,0.00514842291135277,0.637679883043976
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23480.Glycoprotein Acetyls,41900,0.0488493472264388,0.00358591706774672,0.0418209497736552,0.0558777446792223,5.62393559614745e-42
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23481.Concentration of Chylomicrons and Extremely Large VLDL Particles,41900,0.0506400326753738,0.00363569614177886,0.0435140682374873,0.0577659971132604,8.62225293618657e-44
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23482.Total Lipids in Chylomicrons and Extremely Large VLDL,41900,0.048591567524669,0.00361606631291965,0.0415040775513464,0.0556790574979915,6.71996386941831e-41
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23483.Phospholipids in Chylomicrons and Extremely Large VLDL,41900,0.0525112521610651,0.00373571733158945,0.0451892461911497,0.0598332581309804,1.46337609910423e-44
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23484.Cholesterol in Chylomicrons and Extremely Large VLDL,41900,0.0538764677962429,0.00367440347650533,0.0466746369822925,0.0610782986101934,2.66291202897227e-48
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23485.Cholesteryl Esters in Chylomicrons and Extremely Large VLDL,41900,0.055537637706079,0.00367482470849475,0.0483349812774293,0.0627402941347287,3.53508993429223e-51
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23486.Free Cholesterol in Chylomicrons and Extremely Large VLDL,41900,0.0503381908660356,0.0036506051758498,0.0431830047213699,0.0574933770107012,5.8607467631326e-43
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23487.Triglycerides in Chylomicrons and Extremely Large VLDL,41900,0.0440685911926915,0.00354776625583928,0.0371149693312465,0.0510222130541365,3.13244225186059e-35
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,41900,0.0597060619400607,0.00378612020915378,0.0522852663301193,0.0671268575500021,1.59949167516456e-55
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23489.Total Lipids in Very Large VLDL,41900,0.0576810984376934,0.00375930483063026,0.0503128609696581,0.0650493359057288,1.10499780674564e-52
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23490.Phospholipids in Very Large VLDL,41900,0.0584354820129313,0.00375682148527614,0.0510721119017901,0.0657988521240725,4.43821870190129e-54
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23491.Cholesterol in Very Large VLDL,41900,0.057774959007556,0.00373689812054672,0.0504506386912844,0.0650992793238276,1.86407017217378e-53
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23492.Cholesteryl Esters in Very Large VLDL,41900,0.0558324286599503,0.00373501206717425,0.0485118050082888,0.0631530523116118,4.0702526689301e-50
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23493.Free Cholesterol in Very Large VLDL,41900,0.0572941525948968,0.00372644579321651,0.0499903188401924,0.0645979863496012,6.85976485273086e-53
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23494.Triglycerides in Very Large VLDL,41900,0.0554973697024929,0.00377073986163888,0.0481067195736807,0.0628880198313051,1.19361755864581e-48
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23495.Concentration of Large VLDL Particles,41900,0.0565982666373275,0.00373305060312707,0.0492814874551985,0.0639150458194566,1.71509087325808e-51
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23496.Total Lipids in Large VLDL,41900,0.0540452155710183,0.00372518942553718,0.0467438442969654,0.0613465868450712,2.47574775802296e-47
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23497.Phospholipids in Large VLDL,41900,0.0591646724458056,0.00379307845894492,0.0517302386662735,0.0665991062253376,2.27314092176402e-54
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23498.Cholesterol in Large VLDL,41900,0.0557300882406039,0.00375357848455471,0.0483730744108766,0.0630871020703311,1.80528033559598e-49
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23499.Cholesteryl Esters in Large VLDL,41900,0.0507945542412601,0.00373140819108025,0.0434809941867429,0.0581081142957774,6.42389002916413e-42
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23500.Free Cholesterol in Large VLDL,41900,0.0589590253299977,0.00378485422418808,0.0515407110505891,0.0663773396094064,3.11226021305696e-54
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23501.Triglycerides in Large VLDL,41900,0.0488273981870117,0.00367792863066336,0.0416186580709116,0.0560361383031119,5.7439979179325e-40
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23502.Concentration of Medium VLDL Particles,41900,0.0445498247040928,0.00352773172963233,0.0376354705140134,0.0514641788941721,2.37820342573513e-36
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23503.Total Lipids in Medium VLDL,41900,0.0471923254373396,0.0035350557396823,0.0402636161875623,0.0541210346871169,2.16025865652001e-40
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23504.Phospholipids in Medium VLDL,41900,0.044271576450992,0.0035182250842754,0.0373758552858123,0.0511672976161718,4.17849469492047e-36
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23505.Cholesterol in Medium VLDL,41900,0.0271064118546945,0.00346725643882922,0.0203105892345892,0.0339022344747997,5.77710622868453e-15
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23506.Cholesteryl Esters in Medium VLDL,41900,0.0168230335708227,0.00346135463861594,0.0100387784791355,0.02360728866251,1.18578433753258e-06
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23507.Free Cholesterol in Medium VLDL,41900,0.038741758332606,0.00350448684326327,0.03187296411981,0.045610552545402,2.75621290997984e-28
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23508.Triglycerides in Medium VLDL,41900,0.0502064911202141,0.00363005304348707,0.0430915871549794,0.0573213950854487,3.30815808200633e-43
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23509.Concentration of Small VLDL Particles,41900,0.0532238349920217,0.00363673447163247,0.046095835427622,0.0603518345564213,3.97042877177321e-48
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23510.Total Lipids in Small VLDL,41900,0.0538596525649119,0.00363861805276141,0.0467279611814995,0.0609913439483242,3.48815658117935e-49
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23511.Phospholipids in Small VLDL,41900,0.0467161675522646,0.00357213982302179,0.0397147734991419,0.0537175616053873,7.64354298259798e-39
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23512.Cholesterol in Small VLDL,41900,0.0457544976514565,0.00360368926762234,0.0386912666869167,0.0528177286159963,1.00896922062307e-36
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23513.Cholesteryl Esters in Small VLDL,41900,0.0494191631342393,0.00366587941297404,0.0422340394848102,0.0566042867836684,3.77667907577069e-41
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23514.Free Cholesterol in Small VLDL,41900,0.0388059293908613,0.00350910541366248,0.0319280827800828,0.0456837760016398,2.64477550170818e-28
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23515.Triglycerides in Small VLDL,41900,0.0519406855707607,0.00367097458838945,0.0447455753775173,0.059135795764004,4.02258220324048e-45
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23516.Concentration of Very Small VLDL Particles,41900,0.0450341430077236,0.0034827468789378,0.0382079591250055,0.0518603268904417,5.12225614456837e-38
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23517.Total Lipids in Very Small VLDL,41900,0.0444087056123013,0.00350802920245702,0.0375329683754855,0.051284442849117,1.61677202555252e-36
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23518.Phospholipids in Very Small VLDL,41900,0.0451660384476155,0.0034962676257349,0.0383133539011751,0.0520187229940559,5.99709334440187e-38
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23519.Cholesterol in Very Small VLDL,41900,0.0304907975670939,0.00353962468920747,0.0235531331762473,0.0374284619579406,7.83439162826987e-18
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23520.Cholesteryl Esters in Very Small VLDL,41900,0.0258974441398255,0.00356706133237207,0.0189060039283762,0.0328888843512748,4.08097662246217e-13
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23521.Free Cholesterol in Very Small VLDL,41900,0.0397121884989173,0.00350352931527312,0.032845271040982,0.0465791059568526,1.20520857986265e-29
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23522.Triglycerides in Very Small VLDL,41900,0.0548241767751825,0.003559544476375,0.0478474696014875,0.0618008839488775,4.55228657087585e-53
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23523.Concentration of IDL Particles,41900,0.0311487723358048,0.00346249784376594,0.0243622765620236,0.037935268109586,2.65328239533288e-19
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23524.Total Lipids in IDL,41900,0.0286265205760589,0.00353748629013027,0.0216930474474036,0.0355599937047143,6.35839148808382e-16
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23525.Phospholipids in IDL,41900,0.0281647520028023,0.00353551700381015,0.0212351386753344,0.0350943653302702,1.76823782920642e-15
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23526.Cholesterol in IDL,41900,0.0224687903038936,0.00355896153028139,0.0154932257045421,0.0294443549032452,2.81827872633914e-10
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23527.Cholesteryl Esters in IDL,41900,0.0229094866939561,0.00356330750335562,0.0159254039873791,0.0298935694005331,1.32592690099633e-10
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23528.Free Cholesterol in IDL,41900,0.0205785173646251,0.00353439696231211,0.0136510993184934,0.0275059354107569,5.93632602575415e-09
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23529.Triglycerides in IDL,41900,0.0562568482810886,0.00343561521864096,0.0495230424525523,0.0629906541096249,1.11277870964906e-59
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23530.Concentration of Large LDL Particles,41900,0.0304704596935669,0.00342925727910954,0.0237491154265122,0.0371918039606216,7.17604918984406e-19
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23531.Total Lipids in Large LDL,41900,0.032514239764107,0.0034417825423878,0.0257683459810269,0.039260133547187,4.06385902615566e-21
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23532.Phospholipids in Large LDL,41900,0.0307016866099409,0.00345376732215901,0.0239323026585092,0.0374710705613725,6.93050395275731e-19
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23533.Cholesterol in Large LDL,41900,0.0286701283289558,0.00344571984716389,0.0219165174285146,0.0354237392293971,9.60646141198049e-17
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23534.Cholesteryl Esters in Large LDL,41900,0.0309205958776334,0.00343962803855235,0.0241789249220708,0.0376622668331959,2.81457807306217e-19
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23535.Free Cholesterol in Large LDL,41900,0.0219098913802206,0.0034776610537943,0.0150936757147838,0.0287261070456575,3.06669531374158e-10
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23536.Triglycerides in Large LDL,41900,0.061266714457011,0.00339049623788648,0.0546213418307535,0.0679120870832685,3.98391524884622e-72
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23537.Concentration of Medium LDL Particles,41900,0.0419659064635255,0.00345849768700809,0.0351872509969896,0.0487445619300613,1.04927399758347e-33
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23538.Total Lipids in Medium LDL,41900,0.0429634019767612,0.00343545627280543,0.0362299076820626,0.0496968962714599,1.10044244099413e-35
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23539.Phospholipids in Medium LDL,41900,0.0411142876830091,0.00345084678614606,0.0343506279821629,0.0478779473838554,1.46058804672343e-32
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23540.Cholesterol in Medium LDL,41900,0.040126463322784,0.00343272174608581,0.0333983287004558,0.0468545979451121,2.05666663197125e-31
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23541.Cholesteryl Esters in Medium LDL,41900,0.044383221286145,0.00344237339679781,0.0376361694284213,0.0511302731438687,8.27967861638272e-38
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23542.Free Cholesterol in Medium LDL,41900,0.0259960103772537,0.0034247808525649,0.0192834399062265,0.0327085808482809,3.39697544531674e-14
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23543.Triglycerides in Medium LDL,41900,0.0615802989947774,0.00341508620161223,0.0548867300396174,0.0682738679499373,7.837693572656e-72
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23544.Concentration of Small LDL Particles,41900,0.0438001014852375,0.00346045507101719,0.0370176095460438,0.0505825934244311,1.65457612033009e-36
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23545.Total Lipids in Small LDL,41900,0.0407897721632519,0.00341402157551464,0.0340982898752432,0.0474812544512606,9.8130817423249e-33
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23546.Phospholipids in Small LDL,41900,0.0347884118258497,0.00340829214352014,0.0281081592245503,0.0414686644271492,2.26891321113239e-24
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23547.Cholesterol in Small LDL,41900,0.0381555631806315,0.00342542045891514,0.0314417390811578,0.0448693872801051,1.08592311144697e-28
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23548.Cholesteryl Esters in Small LDL,41900,0.0439792657955188,0.00342168369161562,0.0372727657599522,0.0506857658310855,1.38275822863826e-37
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23549.Free Cholesterol in Small LDL,41900,0.0189546181501967,0.00343408148919272,0.012223818431379,0.0256854178690145,3.46212617577682e-08
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23550.Triglycerides in Small LDL,41900,0.0570110119586856,0.00346342174267542,0.0502227053430418,0.0637993185743294,2.76173616590597e-60
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23551.Concentration of Very Large HDL Particles,41900,-0.0165536257490714,0.00399219232135089,-0.0243783226989191,-0.00872892879922365,3.39690625109182e-05
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23552.Total Lipids in Very Large HDL,41900,-0.030330512579663,0.00400059126571269,-0.0381716714604599,-0.0224893536988661,3.64160806891438e-14
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23553.Phospholipids in Very Large HDL,41900,-0.0335803748808494,0.00397888971468128,-0.0413789987216247,-0.0257817510400741,3.5099486838911e-17
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23554.Cholesterol in Very Large HDL,41900,-0.0337601566980066,0.00404466429629965,-0.0416876987187539,-0.0258326146772593,7.69881778292881e-17
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23555.Cholesteryl Esters in Very Large HDL,41900,-0.0371851606481199,0.00406296433681981,-0.0451485707482867,-0.0292217505479531,6.37997145134795e-20
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23556.Free Cholesterol in Very Large HDL,41900,-0.020546081558611,0.00393898918258364,-0.0282665003564749,-0.012825662760747,1.85493430661709e-07
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23557.Triglycerides in Very Large HDL,41900,0.0441126736416211,0.00331549672043586,0.0376143000695668,0.0506110472136754,3.90747541386135e-40
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23558.Concentration of Large HDL Particles,41900,-0.0349726368132698,0.00401846811901911,-0.0428488343265472,-0.0270964392999923,3.60970106108902e-18
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23559.Total Lipids in Large HDL,41900,-0.035196974786579,0.00398514869557987,-0.0430078662299156,-0.0273860833432425,1.15526906781235e-18
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23560.Phospholipids in Large HDL,41900,-0.0315101431869257,0.00394939881920557,-0.0392509648725686,-0.0237693215012828,1.6023012128778e-15
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23561.Cholesterol in Large HDL,41900,-0.0451115537998462,0.00403721170892996,-0.0530244887493489,-0.0371986188503435,7.35334272963628e-29
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23562.Cholesteryl Esters in Large HDL,41900,-0.0487726009871312,0.00404744082663426,-0.0567055850073343,-0.040839616966928,2.88206554290624e-33
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23563.Free Cholesterol in Large HDL,41900,-0.0325007301474854,0.00400120902790092,-0.0403430998421712,-0.0246583604527996,4.95772941255444e-16
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23564.Triglycerides in Large HDL,41900,0.0353328810700343,0.00349627244983874,0.0284801870683503,0.0421855750717182,6.34785079430666e-24
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23565.Concentration of Medium HDL Particles,41900,-0.00249764557659925,0.00368583242825087,-0.00972187713597095,0.00472658598277244,0.498015535065128
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23566.Total Lipids in Medium HDL,41900,0.000606761701154985,0.00362496699791424,-0.00649817361475693,0.0077116970170669,0.867070409654979
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23567.Phospholipids in Medium HDL,41900,0.00508290001073641,0.00356414294143359,-0.00190282015447342,0.0120686201759462,0.153856814783482
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23568.Cholesterol in Medium HDL,41900,-0.0129927805716235,0.00372633415148703,-0.020296395508538,-0.00568916563470888,0.000490513582228872
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23569.Cholesteryl Esters in Medium HDL,41900,-0.0154756581046479,0.00372028101866575,-0.0227674089012328,-0.00818390730806303,3.20514401870973e-05
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23570.Free Cholesterol in Medium HDL,41900,-0.00232174768599253,0.0037459887399457,-0.0096638856162861,0.00502039024430104,0.535402922677165
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23571.Triglycerides in Medium HDL,41900,0.0517306843221188,0.00357508595459163,0.0447235158511192,0.0587378527931184,4.28453430040902e-47
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23572.Concentration of Small HDL Particles,41900,0.02614020297347,0.00344289679011582,0.019392125264843,0.032888280682097,3.34667711352145e-14
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23573.Total Lipids in Small HDL,41900,0.0328981479165579,0.00343575448476247,0.0261640691264235,0.0396322267066924,1.19346233288e-21
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23574.Phospholipids in Small HDL,41900,0.0317769609202731,0.00341797737941488,0.02507772525662,0.0384761965839263,1.66668884322958e-20
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23575.Cholesterol in Small HDL,41900,0.0197315982256589,0.00342801153350331,0.0130126956199924,0.0264505008313254,8.80366030315231e-09
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23576.Cholesteryl Esters in Small HDL,41900,0.0137950768585634,0.00344965522379468,0.00703375261992577,0.0205564010972009,6.39619681574043e-05
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23577.Free Cholesterol in Small HDL,41900,0.0347477502804444,0.00341058546265566,0.0280630027736393,0.0414324977872494,2.74883014450272e-24
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23578.Triglycerides in Small HDL,41900,0.0672257734712864,0.00383990005989929,0.0596995693538837,0.074751977588689,7.2735049300894e-68
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,41521,0.00544555097257332,0.00389686062192199,-0.00219229584639378,0.0130833977915404,0.162311301600915
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,41521,-0.0166742097047705,0.00373450828999343,-0.0239938459531576,-0.00935457345638339,8.0784634372467e-06
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,41521,-0.00584464639537838,0.0037891781398804,-0.013271435549544,0.0015821427587872,0.1229869370938
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,41521,-0.0283199523571137,0.00372653173877301,-0.0356239545651088,-0.0210159501491186,3.17621093154432e-14
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,41521,0.0129653552041681,0.00378383075650712,0.00554904692141416,0.0203816634869221,0.000613282004069299
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,41828,0.0239441444268042,0.00381402011851247,0.0164686649945198,0.0314196238590886,3.53836257143254e-10
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,41828,-0.0289873984830942,0.00384744935295463,-0.0365283992148853,-0.0214463977513032,5.23264584340721e-14
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23586.Cholesteryl Esters to Total Lipids in Very Large VLDL percentage,41828,-0.0293285218637489,0.00382225121059144,-0.0368201342365081,-0.0218369094909897,1.79614171205328e-14
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,41828,-0.0192694833487546,0.00386809036650274,-0.0268509404670999,-0.0116880262304092,6.38395181128277e-07
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,41828,0.0186913190366878,0.00383992599134897,0.0111650640936438,0.0262175739797318,1.14251383203339e-06
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,41900,0.0588020698400297,0.00395976227090062,0.0510409357890645,0.066563203890995,1.73490163379856e-49
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,41900,-0.00768505329200133,0.00372588878235168,-0.0149877953054106,-0.000382311278592037,0.0391691237729918
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23591.Cholesteryl Esters to Total Lipids in Large VLDL percentage,41900,-0.0185795011674904,0.00378031994157129,-0.0259889282529702,-0.0111700740820107,8.99341824372179e-07
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,41900,0.0241244458929307,0.00378277561142556,0.0167102056945366,0.0315386860913248,1.86021940975355e-10
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,41900,-0.0153801227784764,0.00380232489892915,-0.0228326795803775,-0.00792756597657525,5.2635160770947e-05
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,41900,0.0040678360961617,0.00365480806377212,-0.00309558770883166,0.0112312599011551,0.265724464935862
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,41900,-0.0198148348590886,0.0037779457852467,-0.0272196085981721,-0.0124100611200051,1.58791484531927e-07
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,41900,-0.0230714393258472,0.00380057086869627,-0.0305205582284919,-0.0156223204232025,1.30966531159866e-09
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,41900,-0.00970167468505574,0.00369844437258612,-0.0169506256553245,-0.00245272371478694,0.00872133599159746
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,41900,0.0144959984163181,0.00374847415369921,0.00714898907506761,0.0218430077575685,0.00011062859023805
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,41900,-0.0181128613637544,0.00368023678578276,-0.0253261254638886,-0.0108995972636202,8.68430069542699e-07
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,41900,-0.00699437651873461,0.00355616058581585,-0.0139644512669337,-2.43017705355451e-05,0.0492231425393292
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23601.Cholesteryl Esters to Total Lipids in Small VLDL percentage,41900,0.000650109648381565,0.00350640843907356,-0.00622245089220262,0.00752267018896575,0.85291332137154
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,41900,-0.0171907632098329,0.00371220592003432,-0.0244666868131002,-0.00991483960656562,3.67571775838518e-06
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,41900,0.0103925513155492,0.00359104128541797,0.00335411039613002,0.0174309922349684,0.00380959936245446
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23604.Phospholipids to Total Lipids in Very Small VLDL percentage,41900,0.0126319918343196,0.00348769271496966,0.00579611411297902,0.0194678695556601,0.000293562148344872
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23605.Cholesterol to Total Lipids in Very Small VLDL percentage,41900,-0.0245293419241538,0.00367165990991622,-0.0317257953475896,-0.0173328885007181,2.47227603223467e-11
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23606.Cholesteryl Esters to Total Lipids in Very Small VLDL percentage,41900,-0.0260691766199569,0.00372239385252188,-0.0333650685708998,-0.018773284669014,2.61947071141145e-12
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23607.Free Cholesterol to Total Lipids in Very Small VLDL percentage,41900,-0.00846164505204459,0.0032419349679485,-0.0148158375892237,-0.00210745251486553,0.00906277755206243
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23608.Triglycerides to Total Lipids in Very Small VLDL percentage,41900,0.0238316371434035,0.00362502632287713,0.0167265855505643,0.0309366887362427,5.07421123127076e-11
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23609.Phospholipids to Total Lipids in IDL percentage,41900,-0.0120822617059477,0.00340825186981471,-0.0187624353707845,-0.00540208804111084,0.000393957293520291
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,41900,-0.0173588700587478,0.00357504480318438,-0.0243659578729892,-0.0103517822445064,1.21407772901956e-06
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23611.Cholesteryl Esters to Total Lipids in IDL percentage,41900,-0.0123612939174863,0.00352665730104765,-0.0192735422275397,-0.00544904560743292,0.000457934497736051
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,41900,-0.0173643062736939,0.00327447836119789,-0.0237822838616417,-0.010946328685746,1.15787826239824e-07
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,41900,0.02619360765068,0.00359324648139131,0.0191508445471531,0.033236370754207,3.28237352994819e-13
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23614.Phospholipids to Total Lipids in Large LDL percentage,41900,-0.0208269268370281,0.0034903966553325,-0.0276681042814798,-0.0139857493925764,2.47916939966662e-09
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23615.Cholesterol to Total Lipids in Large LDL percentage,41900,-0.0207045358322804,0.00355526231676259,-0.0276728499731351,-0.0137362216914257,5.89130742980756e-09
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23616.Cholesteryl Esters to Total Lipids in Large LDL percentage,41900,0.00123278682703204,0.00340905315043086,-0.00544895734781244,0.00791453100187653,0.717640659433929
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23617.Free Cholesterol to Total Lipids in Large LDL percentage,41900,-0.0313880923985073,0.00380636285891391,-0.0388485636019786,-0.0239276211950361,1.78733667697418e-16
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23618.Triglycerides to Total Lipids in Large LDL percentage,41900,0.0280038078316007,0.00349625113167622,0.0211511556135153,0.0348564600496861,1.245374922739e-15
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23619.Phospholipids to Total Lipids in Medium LDL percentage,41900,-0.0311673123268018,0.00358474257997762,-0.0381934077835579,-0.0241412168700456,3.89020260221553e-18
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23620.Cholesterol to Total Lipids in Medium LDL percentage,41900,-0.00983438562481526,0.00354609706081933,-0.0167847358640211,-0.00288403538560938,0.00555684864386193
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23621.Cholesteryl Esters to Total Lipids in Medium LDL percentage,41900,0.035703293009024,0.00357739260812232,0.0286916034971042,0.0427149825209437,2.24741993378484e-23
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23622.Free Cholesterol to Total Lipids in Medium LDL percentage,41900,-0.0443349347996429,0.00366503371001638,-0.051518400871275,-0.0371514687280108,1.64773955526058e-33
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23623.Triglycerides to Total Lipids in Medium LDL percentage,41900,0.0239918992446216,0.00348809148776134,0.0171552399286094,0.0308285585606338,6.33092996459576e-12
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23624.Phospholipids to Total Lipids in Small LDL percentage,41900,-0.0404710012617326,0.00355260300787345,-0.0474341031571646,-0.0335078993663006,6.31317810064267e-30
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23625.Cholesterol to Total Lipids in Small LDL percentage,41900,0.00279005788192898,0.0034784327465036,-0.00402767030121807,0.00960778606507604,0.422508286133357
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23626.Cholesteryl Esters to Total Lipids in Small LDL percentage,41900,0.0411666669308181,0.00352158539305484,0.0342643595604306,0.0480689743012056,2.04688390479547e-31
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23627.Free Cholesterol to Total Lipids in Small LDL percentage,41900,-0.0381264156483939,0.00348672688527837,-0.0449604003435395,-0.0312924309532483,1.03179652787228e-27
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23628.Triglycerides to Total Lipids in Small LDL percentage,41900,0.0330009117715366,0.00355314339460582,0.0260367507181092,0.039965072824964,1.81618604319372e-20
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23629.Phospholipids to Total Lipids in Very Large HDL percentage,41888,-0.0358838281758288,0.00379319085892066,-0.0433184822593133,-0.0284491740923444,3.58758584314321e-21
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23630.Cholesterol to Total Lipids in Very Large HDL percentage,41888,-0.000502862764823012,0.00330227516513045,-0.0069753220884787,0.00596959655883268,0.878970248915439
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23631.Cholesteryl Esters to Total Lipids in Very Large HDL percentage,41888,-0.0166972189870088,0.00306956395952991,-0.0227135643476874,-0.0106808736263302,5.43436358364515e-08
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23632.Free Cholesterol to Total Lipids in Very Large HDL percentage,41888,0.034118604494671,0.00392794902487413,0.0264198244059178,0.0418173845834243,4.18460702429082e-18
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23633.Triglycerides to Total Lipids in Very Large HDL percentage,41888,0.0596484513400743,0.00367813072614851,0.0524393151168232,0.0668575875633254,1.39375140970046e-58
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23634.Phospholipids to Total Lipids in Large HDL percentage,41900,0.0293231267690314,0.00349237451547513,0.0224780727187002,0.0361681808193627,5.0692468856403e-17
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23635.Cholesterol to Total Lipids in Large HDL percentage,41900,-0.0527151299485798,0.0036722733897955,-0.059912785792579,-0.0455174741045806,2.20403166471574e-46
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23636.Cholesteryl Esters to Total Lipids in Large HDL percentage,41900,-0.0538057258027076,0.00352869794787892,-0.0607219737805503,-0.0468894778248649,4.67228694214978e-52
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23637.Free Cholesterol to Total Lipids in Large HDL percentage,41900,-0.00789565452937966,0.00354514440514769,-0.0148441375634691,-0.000947171495290179,0.0259522980593724
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23638.Triglycerides to Total Lipids in Large HDL percentage,41900,0.0563838857059951,0.00352213849617291,0.0494804942534962,0.063287277158494,3.81191379565846e-57
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23639.Phospholipids to Total Lipids in Medium HDL percentage,41900,0.0354818395425568,0.00377556108592167,0.0280817398141503,0.0428819392709633,6.4705821420123e-21
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23640.Cholesterol to Total Lipids in Medium HDL percentage,41900,-0.0513866376114339,0.00375858287783155,-0.0587534600519837,-0.0440198151708841,2.88798045454634e-42
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23641.Cholesteryl Esters to Total Lipids in Medium HDL percentage,41900,-0.0514616566629478,0.0035687066290067,-0.0584563216558009,-0.0444669916700947,8.69383973845541e-47
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23642.Free Cholesterol to Total Lipids in Medium HDL percentage,41900,-0.0113593879378489,0.00394435005501775,-0.0190903140456837,-0.0036284618300141,0.00398418993240612
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23643.Triglycerides to Total Lipids in Medium HDL percentage,41900,0.0575944937476358,0.00369978330950473,0.0503429184610065,0.064846069034265,3.66410933146488e-54
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23644.Phospholipids to Total Lipids in Small HDL percentage,41900,0.000311478711760676,0.00347407965924462,-0.00649771742035878,0.00712067484388014,0.928560416376615
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23645.Cholesterol to Total Lipids in Small HDL percentage,41900,-0.0321845570358704,0.003424415770887,-0.0388964119468089,-0.0254727021249319,6.4226202635385e-21
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23646.Cholesteryl Esters to Total Lipids in Small HDL percentage,41900,-0.0339824300450968,0.00337452854470017,-0.0405965059927091,-0.0273683540974844,9.09685802353462e-24
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23647.Free Cholesterol to Total Lipids in Small HDL percentage,41900,0.0122627924392359,0.00367623942631613,0.00505736316365623,0.0194682217148155,0.000853211043251197
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23648.Triglycerides to Total Lipids in Small HDL percentage,41900,0.0580474947681389,0.00385517832763273,0.0504913452459788,0.0656036442902991,8.13899304544901e-51
PON2,Serum paraoxonase/arylesterase 2,Working and living environment,X24003.Nitrogen dioxide air pollution; 2010,51531,-0.0017632494864895,0.0029690545343765,-0.00758259637386744,0.00405609740088844,0.552601078096979
PON2,Serum paraoxonase/arylesterase 2,Working and living environment,X24004.Nitrogen oxides air pollution; 2010,51531,-0.000407889779973231,0.00288480571187876,-0.00606210897525559,0.00524632941530913,0.887561151496303
PON2,Serum paraoxonase/arylesterase 2,Working and living environment,X24005.Particulate matter air pollution (pm10); 2010,50012,-0.000632271061590536,0.00274412108783795,-0.00601074839375291,0.00474620627057184,0.817775924313073
PON2,Serum paraoxonase/arylesterase 2,Working and living environment,X24006.Particulate matter air pollution (pm2.5); 2010,50012,-0.000450776572070837,0.00298947835577822,-0.00631015414939614,0.00540860100525447,0.880144607963593
PON2,Serum paraoxonase/arylesterase 2,Working and living environment,X24007.Particulate matter air pollution (pm2.5) absorbance; 2010,50012,-0.000695164367238315,0.00296195149652491,-0.00650058930042715,0.00511026056595052,0.814445312279201
PON2,Serum paraoxonase/arylesterase 2,Working and living environment,X24008.Particulate matter air pollution 2.5-10um; 2010,50012,-0.00183133933440517,0.00272429137215962,-0.00717095042383802,0.00350827175502768,0.501447121471813
PON2,Serum paraoxonase/arylesterase 2,Working and living environment,X24009.Traffic intensity on the nearest road,51531,0.00252631728299088,0.0681199447903195,-0.130988774506035,0.136041409072017,0.970416511644907
PON2,Serum paraoxonase/arylesterase 2,Working and living environment,X24010.Inverse distance to the nearest road,51531,0.00242465292418319,0.00259560336875241,-0.00266272967857153,0.00751203552693792,0.350242313231802
PON2,Serum paraoxonase/arylesterase 2,Working and living environment,X24011.Traffic intensity on the nearest major road,51531,0.00126598087834424,0.00259021386959114,-0.00381083830605439,0.00634280006274286,0.625019588727809
PON2,Serum paraoxonase/arylesterase 2,Working and living environment,X24012.Inverse distance to the nearest major road,51531,-0.000307787914464211,0.0026231300075922,-0.00544912272934493,0.00483354690041651,0.90659472554543
PON2,Serum paraoxonase/arylesterase 2,Working and living environment,X24013.Total traffic load on major roads,51531,-0.0344083159323162,0.0473681614853361,-0.127249912443575,0.0584332805789425,0.467599926520527
PON2,Serum paraoxonase/arylesterase 2,Working and living environment,X24015.Sum of road length of major roads within 100m,51531,-0.0204373049161845,0.0460665542594982,-0.110727751264801,0.069853141432432,0.6573017493838
PON2,Serum paraoxonase/arylesterase 2,Working and living environment,X24016.Nitrogen dioxide air pollution; 2005,51531,-0.00299764405942974,0.00298065262151487,-0.00883972319759888,0.0028444350787394,0.314570237835108
PON2,Serum paraoxonase/arylesterase 2,Working and living environment,X24017.Nitrogen dioxide air pollution; 2006,51531,-0.00349624801045704,0.00298052682967078,-0.00933808059661178,0.0023455845756977,0.24079587621816
PON2,Serum paraoxonase/arylesterase 2,Working and living environment,X24018.Nitrogen dioxide air pollution; 2007,51531,-0.00338546895175206,0.00294553438383009,-0.00915871634405903,0.00238777844055491,0.250421016207424
PON2,Serum paraoxonase/arylesterase 2,Working and living environment,X24019.Particulate matter air pollution (pm10); 2007,51496,-0.00241454238399788,0.00288257683130013,-0.00806439297334614,0.00323530820535037,0.402245420092117
PON2,Serum paraoxonase/arylesterase 2,Working and living environment,X24020.Average daytime sound level of noise pollution,51531,-0.000309700978594339,0.00259458357532235,-0.00539508478622615,0.00477568282903747,0.904987689506592
PON2,Serum paraoxonase/arylesterase 2,Working and living environment,X24021.Average evening sound level of noise pollution,51531,-0.00031920851000395,0.00259457510048115,-0.00540457570694699,0.00476615868693909,0.902085050183717
PON2,Serum paraoxonase/arylesterase 2,Working and living environment,X24022.Average night-time sound level of noise pollution,51531,-0.000308521181841274,0.00259465631369298,-0.00539404755667952,0.00477700519299697,0.905350571053965
PON2,Serum paraoxonase/arylesterase 2,Working and living environment,X24023.Average 16-hour sound level of noise pollution,51531,-0.00030838373442977,0.00259466347826124,-0.00539392415182179,0.00477715668296225,0.905392799529545
PON2,Serum paraoxonase/arylesterase 2,Working and living environment,X24024.Average 24-hour sound level of noise pollution,51531,-0.000307686879654045,0.0025946721555249,-0.00539324430448284,0.00477787054517475,0.905605896242784
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X2405.Number of children fathered,51525,0.0001686961102719,0.0358569069382666,-0.0701108414887306,0.0704482337092744,0.996246244617816
PON2,Serum paraoxonase/arylesterase 2,Working and living environment,"X24500.Greenspace percentage, buffer 1000m",49071,8.09437396873218e-05,0.00305430761513861,-0.00590549918598436,0.006067386665359,0.978857593837644
PON2,Serum paraoxonase/arylesterase 2,Working and living environment,"X24501.Domestic garden percentage, buffer 1000m",49071,0.0022093567173618,0.00274559809963201,-0.00317201555791694,0.00759072899264053,0.421007646189817
PON2,Serum paraoxonase/arylesterase 2,Working and living environment,"X24502.Water percentage, buffer 1000m",49071,-0.00248247565078555,0.00277073069890763,-0.00791310782064451,0.0029481565190734,0.370282392754384
PON2,Serum paraoxonase/arylesterase 2,Working and living environment,"X24503.Greenspace percentage, buffer 300m",49071,0.00314217340467772,0.00287234163436215,-0.00248761619867209,0.00877196300802753,0.273993555417589
PON2,Serum paraoxonase/arylesterase 2,Working and living environment,"X24504.Domestic garden percentage, buffer 300m",49071,-0.0020103797816991,0.00277276476111801,-0.00744499871349039,0.00342423915009219,0.468432588634853
PON2,Serum paraoxonase/arylesterase 2,Working and living environment,"X24505.Water percentage, buffer 300m",49071,-0.00050715368521298,0.0027834728216011,-0.00596276041555114,0.00494845304512518,0.855426185182435
PON2,Serum paraoxonase/arylesterase 2,Working and living environment,"X24506.Natural environment percentage, buffer 1000m",51615,-6.28822095848815e-05,0.00294404352662129,-0.00583320752176261,0.00570744310259285,0.982959360499444
PON2,Serum paraoxonase/arylesterase 2,Working and living environment,"X24507.Natural environment percentage, buffer 300m",51615,0.00257631981856428,0.00275726059825483,-0.00282791095401518,0.00798055059114374,0.350119460192237
PON2,Serum paraoxonase/arylesterase 2,Working and living environment,X24508.Distance (Euclidean) to coast,51615,-0.00200638333545251,0.00260328202177663,-0.0071088160981347,0.00309604942722968,0.440884967422343
PON2,Serum paraoxonase/arylesterase 2,Lifestyle factors,X2867.Age started smoking in former smokers,35377,-0.00796892118357702,0.00475526975492374,-0.0172892499032276,0.00135140753607352,0.0938218498782052
PON2,Serum paraoxonase/arylesterase 2,Mental health,"X28735.Feeling anxious, nervous or on edge over the last 2 weeks",36883,-0.0464454726044644,0.0720936311613377,-0.187748989680686,0.0948580444717576,0.519438813895521
PON2,Serum paraoxonase/arylesterase 2,Mental health,X28736.Not being able to stop or control worrying over the last 2 weeks,36882,0.0621059272775275,0.0822968811110652,-0.0991959597001603,0.223407814255215,0.450476204121307
PON2,Serum paraoxonase/arylesterase 2,Mental health,X28737.Little interest or pleasure in doing things over the last 2 weeks,36881,0.102814702168462,0.0768101174721913,-0.0477331280770329,0.253362532413957,0.180751765987216
PON2,Serum paraoxonase/arylesterase 2,Mental health,"X28738.Feeling down, depressed or hopeless over the last 2 weeks",36871,0.053308952590421,0.0771141658652902,-0.0978348125055479,0.20445271768639,0.489397011138598
PON2,Serum paraoxonase/arylesterase 2,Mental health,X28739.Difficulty with standing for long periods,36887,0.0774055526299004,0.0652680891173222,-0.0505199020400511,0.205331007299852,0.235670842365424
PON2,Serum paraoxonase/arylesterase 2,Mental health,X28740.Difficulty with taking care of household responsibilities,36904,-0.0356649424767366,0.0760000942352537,-0.184625127177834,0.113295242224361,0.63888542391854
PON2,Serum paraoxonase/arylesterase 2,Mental health,X28741.Difficulty learning a new task,36859,0.07746424209151,0.0896024486056025,-0.0981565571754709,0.253085041358491,0.387320471467013
PON2,Serum paraoxonase/arylesterase 2,Mental health,X28742.Difficulty with joining in community activities,36443,-0.0227160390163324,0.0828302292438178,-0.185063288334215,0.13963121030155,0.78390113560709
PON2,Serum paraoxonase/arylesterase 2,Mental health,X28743.Difficulty with being emotionally affected by health problems,36856,-0.0236929922806484,0.0722900769662128,-0.165381543134425,0.117995558573129,0.743109850099302
PON2,Serum paraoxonase/arylesterase 2,Mental health,X28744.Difficulty with concentrating on doing something for ten minutes,36910,0.120943389198509,0.0969627368275799,-0.0691035749835478,0.310990353380566,0.212315999133912
PON2,Serum paraoxonase/arylesterase 2,Lifestyle factors,X2887.Number of cigarettes previously smoked daily,34788,0.0729144194848471,0.0668068946894452,-0.0580270941064655,0.20385593307616,0.275130362675085
PON2,Serum paraoxonase/arylesterase 2,Lifestyle factors,X2897.Age stopped smoking,35375,0.0166199997283894,0.00503076796442539,0.00675969451811559,0.0264803049386631,0.000959230409864012
PON2,Serum paraoxonase/arylesterase 2,Mental health,X29001#0.Mental health conditions experienced by first degree blood relatives_None of the above,35961,0.00911689313156015,0.0100700504322921,-0.0106204057157323,0.0288541919788526,0.365311048029257
PON2,Serum paraoxonase/arylesterase 2,Mental health,X29001#1.Mental health conditions experienced by first degree blood relatives_Depression,35961,-0.00820366906114464,0.0113870780762638,-0.0305223420906217,0.0141150039683324,0.471279031055098
PON2,Serum paraoxonase/arylesterase 2,Mental health,X29001#3.Mental health conditions experienced by first degree blood relatives_Schizophrenia,35961,0.0926928042995717,0.0375791667015902,0.0190376375644549,0.166347971034689,0.0136628419541893
PON2,Serum paraoxonase/arylesterase 2,Mental health,X29001#4.Mental health conditions experienced by first degree blood relatives_Any other type of psychosis or psychotic illness,35961,-0.042648424534999,0.0374070833440853,-0.115966307889406,0.0306694588194082,0.254274957331313
PON2,Serum paraoxonase/arylesterase 2,Mental health,X29001#5.Mental health conditions experienced by first degree blood relatives_A personality disorder,35961,-0.014842910170708,0.0459007241773384,-0.104808329558291,0.0751225092168753,0.74642434808445
PON2,Serum paraoxonase/arylesterase 2,Mental health,X29001#7.Mental health conditions experienced by first degree blood relatives_Attention deficit or attention deficit and hyperactivity disorder,35961,-0.0698958172873891,0.0415395126288213,-0.151313262039879,0.0115216274651006,0.0924882779324038
PON2,Serum paraoxonase/arylesterase 2,Mental health,X29001#8.Mental health conditions experienced by first degree blood relatives_An anxiety disorder,35961,-0.0212925552114064,0.0171252140169834,-0.0548579746846938,0.012272864261881,0.213780197473576
PON2,Serum paraoxonase/arylesterase 2,Mental health,X29001#9.Mental health conditions experienced by first degree blood relatives_An eating disorder,35961,-0.114645934419712,0.0320591309065014,-0.177481830996454,-0.051810037842969,0.000351026144894633
PON2,Serum paraoxonase/arylesterase 2,Mental health,X29002.Recent lack of interest or pleasure in doing things,35917,0.228539172137702,0.0779689114747671,0.0757201056471589,0.381358238628246,0.00338746750282603
PON2,Serum paraoxonase/arylesterase 2,Mental health,X29003.Recent feelings of depression,35918,0.236559669777915,0.0772296850668077,0.0851894870469716,0.387929852508858,0.00219877691401547
PON2,Serum paraoxonase/arylesterase 2,Mental health,"X29004.Trouble falling or staying asleep, or sleeping too much",35922,0.0930107415658963,0.0607248754426912,-0.0260100143017785,0.212031497433571,0.125645998450882
PON2,Serum paraoxonase/arylesterase 2,Mental health,X29005.Recent feelings of tiredness or low energy,35923,0.135849888764635,0.0601068113784322,0.0180405384629082,0.253659239066363,0.0238417354258305
PON2,Serum paraoxonase/arylesterase 2,Mental health,X29006.Recent poor appetite or overeating,35929,0.223450374683947,0.0937558800336033,0.0396888498180847,0.40721189954981,0.0171825452299065
PON2,Serum paraoxonase/arylesterase 2,Mental health,X29007.Recent feelings of inadequacy,35906,0.103274619924856,0.0841921342575488,-0.0617419632199397,0.268291203069651,0.219992196732179
PON2,Serum paraoxonase/arylesterase 2,Mental health,X29008.Recent trouble concentrating on things,35924,0.101301865067397,0.0799437038680267,-0.0553877945139354,0.257991524648729,0.205136591987478
PON2,Serum paraoxonase/arylesterase 2,Mental health,X29009.Recent changes in speed or amount of moving or speaking,35923,0.289095419631745,0.137607155680915,0.0193853944971521,0.558805444766339,0.0356860550033146
PON2,Serum paraoxonase/arylesterase 2,Mental health,X29010.Recent thoughts of suicide or self-harm,35904,0.245491467469494,0.147464282281805,-0.0435385258028444,0.534521460741833,0.096005134875888
PON2,Serum paraoxonase/arylesterase 2,Mental health,X29038#0.Substances taken for depression_None of options listed,35874,-0.00975675150909207,0.0197800829985548,-0.0485257141862595,0.0290122111680753,0.621842786779225
PON2,Serum paraoxonase/arylesterase 2,Mental health,X29038#1.Substances taken for depression_Drugs or alcohol (more than once),35874,-0.0384751618744237,0.0362998406646774,-0.109622849577191,0.032672525828344,0.289213246507772
PON2,Serum paraoxonase/arylesterase 2,Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),35874,-0.0548333386573717,0.0218099360505446,-0.097580813316439,-0.0120858639983043,0.0119535523319559
PON2,Serum paraoxonase/arylesterase 2,Mental health,X29038#3.Substances taken for depression_Unprescribed medication (more than once),35874,-0.10175456503775,0.0647841865835414,-0.228731570741491,0.025222440665991,0.116302863210432
PON2,Serum paraoxonase/arylesterase 2,Mental health,X29039#1.Use of specific medications_Citalopram (sometimes called Cipramil),35874,-0.105625394537925,0.0431723381109093,-0.190243177235308,-0.0210076118405433,0.0144446304978656
PON2,Serum paraoxonase/arylesterase 2,Mental health,X29039#2.Use of specific medications_Fluoxetine (Prozac or Oxactin),35874,-0.0851741852854377,0.0489846687758054,-0.181184136086016,0.0108357655151409,0.0821135384989315
PON2,Serum paraoxonase/arylesterase 2,Mental health,X29039#3.Use of specific medications_Sertraline (Lustral),35874,-0.107886844881517,0.0518300357489031,-0.209473714949367,-0.00629997481366659,0.0374184166827658
PON2,Serum paraoxonase/arylesterase 2,Mental health,X29039#5.Use of specific medications_Amitriptyline (Elavil),35874,-0.0606348440412621,0.0607981305620382,-0.179799179942857,0.0585294918603327,0.318645157130045
PON2,Serum paraoxonase/arylesterase 2,Mental health,X29039#7.Use of specific medications_Other antidepressant(s),35874,-0.0538676313234942,0.0426030451489511,-0.137369599815438,0.02963433716845,0.20612413277169
PON2,Serum paraoxonase/arylesterase 2,Mental health,X29047#0.Activities undertaken to treat depression_None of options listed,35874,-0.0126983695804987,0.0185615074755027,-0.049078924232484,0.0236821850714866,0.493918769282552
PON2,Serum paraoxonase/arylesterase 2,Mental health,X29051#0.Manifestations of mania or irritability_None of options listed,35874,-0.00127256721765022,0.0298937033592068,-0.0598642258016956,0.0573190913663952,0.96604568498676
PON2,Serum paraoxonase/arylesterase 2,Mental health,X29051#1.Manifestations of mania or irritability_More active than usual,35874,-0.0653214042128824,0.0472149989005468,-0.157862802057954,0.0272199936321893,0.16655761126624
PON2,Serum paraoxonase/arylesterase 2,Mental health,X29051#2.Manifestations of mania or irritability_More confident than usual,35874,-0.121485333692816,0.0575302414737,-0.234244606981268,-0.00872606040436374,0.0347481046904264
PON2,Serum paraoxonase/arylesterase 2,Mental health,X29051#3.Manifestations of mania or irritability_Easily distracted,35874,-0.04249492508888,0.034629097234867,-0.110367955669219,0.0253781054914593,0.219807794543189
PON2,Serum paraoxonase/arylesterase 2,Mental health,X29051#4.Manifestations of mania or irritability_More creative or had more ideas than usual,35874,-0.0458242311190134,0.0532199674374111,-0.150135367296339,0.0584869050583123,0.389247390741757
PON2,Serum paraoxonase/arylesterase 2,Mental health,X29051#5.Manifestations of mania or irritability_Neded less sleep than usual,35874,0.00595991971145673,0.0523659402049791,-0.0966773230903023,0.108597162513216,0.909389250359585
PON2,Serum paraoxonase/arylesterase 2,Mental health,X29051#6.Manifestations of mania or irritability_Thoughts were racing,35874,-0.027076684148287,0.0300336248654462,-0.0859425888845616,0.0317892205879877,0.367328117499997
PON2,Serum paraoxonase/arylesterase 2,Mental health,X29051#7.Manifestations of mania or irritability_More restless than usual,35874,-0.00978659332418539,0.0285080138560585,-0.06566230048206,0.0460891138336893,0.731388185796164
PON2,Serum paraoxonase/arylesterase 2,Mental health,X29051#8.Manifestations of mania or irritability_More talkative than usual,35874,-0.0561714842190535,0.0421946751020362,-0.138873047419045,0.0265300789809376,0.183149864242552
PON2,Serum paraoxonase/arylesterase 2,Mental health,X29058.Recent feelings or nervousness or anxiety,35807,0.0416850201087019,0.076011595442774,-0.107297706959135,0.190667747176539,0.583431908896449
PON2,Serum paraoxonase/arylesterase 2,Mental health,X29059.Recent inability to stop or control worrying,35813,0.156625790758898,0.0806205965262531,-0.00139057843255833,0.314642159950354,0.0520850552562162
PON2,Serum paraoxonase/arylesterase 2,Mental health,X29060.Recent worrying too much about different things,35811,0.130380997675532,0.0715871622231536,-0.00992984028184865,0.270691835632914,0.0686041810543108
PON2,Serum paraoxonase/arylesterase 2,Mental health,X29061.Recent trouble relaxing,35808,0.109140396964615,0.076347332466374,-0.0405003746694783,0.258781168598708,0.15289683346162
PON2,Serum paraoxonase/arylesterase 2,Mental health,X29062.Recent restlessness,35816,0.171032757200898,0.105258174394919,-0.035273264613142,0.377338779014939,0.104230084348339
PON2,Serum paraoxonase/arylesterase 2,Mental health,X29063.Recent easy annoyance or irritability,35806,0.1510053704304,0.073368253836959,0.00720359290996028,0.294807147950839,0.0396083585085792
PON2,Serum paraoxonase/arylesterase 2,Mental health,X29064.Recent feelings of foreboding,35808,0.127589589189009,0.0916116805386079,-0.0519693046666625,0.307148483044681,0.163746886111841
PON2,Serum paraoxonase/arylesterase 2,Mental health,X29065#1.Symptoms of panic attack_Heart was pounding or racing,35874,-0.0269601828135306,0.0232837817291436,-0.0725963950026522,0.0186760293755909,0.246944758359877
PON2,Serum paraoxonase/arylesterase 2,Mental health,X29065#11.Symptoms of panic attack_Felt like things weren't real or detached from self,35874,-0.0330843652831853,0.0353925543983416,-0.102453771903935,0.0362850413375643,0.349931068957293
PON2,Serum paraoxonase/arylesterase 2,Mental health,X29065#12.Symptoms of panic attack_Afraid of losing control or 'going crazy',35874,-0.0722416976207787,0.0486684519403094,-0.167631863423785,0.0231484681822277,0.137755711986443
PON2,Serum paraoxonase/arylesterase 2,Mental health,X29065#13.Symptoms of panic attack_Afraid I was going to die,35874,-0.0497063626638862,0.0486035581861704,-0.14496933670878,0.0455566113810078,0.306488550749805
PON2,Serum paraoxonase/arylesterase 2,Mental health,X29065#2.Symptoms of panic attack_Sweating,35874,-0.0177586521489623,0.0302198176233535,-0.0769894946907352,0.0414721903928105,0.556786010151607
PON2,Serum paraoxonase/arylesterase 2,Mental health,X29065#3.Symptoms of panic attack_Trembling or shaking,35874,-0.0277846401446064,0.0376568771669633,-0.101592119391855,0.0460228391026417,0.46063726131487
PON2,Serum paraoxonase/arylesterase 2,Mental health,X29065#6.Symptoms of panic attack_Pain or discomfort in chest,35874,0.0281601181491061,0.0362849149406652,-0.0429583151345976,0.0992785514328098,0.437725009465202
PON2,Serum paraoxonase/arylesterase 2,Mental health,X29065#7.Symptoms of panic attack_Nauseous or felt sick in the stomach,35874,0.00400423718419713,0.0357098472501786,-0.0659870634261529,0.0739955377945472,0.910721381915807
PON2,Serum paraoxonase/arylesterase 2,Mental health,X29065#9.Symptoms of panic attack_Felt hot or cold,35874,0.00501047145469412,0.0450791766432501,-0.083344714766076,0.0933656576754643,0.911501856812713
PON2,Serum paraoxonase/arylesterase 2,Mental health,X29076.Felt loved as a child,35777,-0.0387913976447124,0.0616033419076228,-0.159533947783653,0.0819511524942283,0.528913344460356
PON2,Serum paraoxonase/arylesterase 2,Mental health,X29077.Physically abused by family as a child,35788,0.110938649353477,0.079320979797329,-0.0445304710492878,0.266407769756242,0.161974890392287
PON2,Serum paraoxonase/arylesterase 2,Mental health,X29078.Felt hated by family member as a child,35782,0.135221855320955,0.0894780691990891,-0.0401551603092596,0.31059887095117,0.130774123531146
PON2,Serum paraoxonase/arylesterase 2,Mental health,X29079.Sexually molested as a child,35764,0.139907426143964,0.131803855091714,-0.118428129835795,0.398242982123723,0.28850668391938
PON2,Serum paraoxonase/arylesterase 2,Mental health,X29080.Someone to take to doctor when needed as a child,35774,0.0982214387633771,0.0939439716117254,-0.0859087455956047,0.282351623122359,0.295812349506552
PON2,Serum paraoxonase/arylesterase 2,Mental health,X29081.Stopped from seeing friends or family by partner or ex-partner as an adult,35786,-0.0121127569001489,0.135560267229991,-0.27781088067093,0.253585366870632,0.928803628504099
PON2,Serum paraoxonase/arylesterase 2,Mental health,X29082.Belittlement by partner or ex-partner as an adult,35763,0.0844451425402853,0.114476268717711,-0.139928344146428,0.308818629226999,0.460742182045006
PON2,Serum paraoxonase/arylesterase 2,Mental health,X29083.Physical violence by partner or ex-partner as an adult,35798,0.0395098564718304,0.131181583201423,-0.217606046602959,0.29662575954662,0.763282527400166
PON2,Serum paraoxonase/arylesterase 2,Mental health,X29084.Sexual interference by partner or ex-partner without consent as an adult,35791,-0.540284847461554,0.395405684144031,-1.31527998838385,0.234710293460747,0.171854178282039
PON2,Serum paraoxonase/arylesterase 2,Mental health,X29085.Sexual intercourse by partner or ex-partner without consent as an adult,35784,-0.509331382077921,0.245709392202704,-0.990921790795221,-0.0277409733606205,0.0382170175281443
PON2,Serum paraoxonase/arylesterase 2,Mental health,X29086.Experienced a violent or sexual assault,35803,0.0794694069854949,0.139928886786453,-0.194791211115953,0.353730025086943,0.570102173414687
PON2,Serum paraoxonase/arylesterase 2,Mental health,X29087.Experienced a life-threatening injury or illness,35794,0.0195622083989328,0.0699991681756359,-0.117636161225314,0.156760578023179,0.77989722569929
PON2,Serum paraoxonase/arylesterase 2,Mental health,X29088.Experienced a marital separation or divorce,35793,0.0662355496751884,0.0698121361561618,-0.0705962371908887,0.203067336541265,0.342770288599644
PON2,Serum paraoxonase/arylesterase 2,Mental health,X29089.Experienced the death of a spouse or partner,35805,-0.0915859571527476,0.105447730708291,-0.298263509340999,0.115091595035504,0.385125719334819
PON2,Serum paraoxonase/arylesterase 2,Mental health,X29090.Experienced the death of a close friend or family member due to suicide,35798,0.0106194147367945,0.085056286338513,-0.156090906486691,0.17732973596028,0.900644510945155
PON2,Serum paraoxonase/arylesterase 2,Lifestyle factors,X29091.Frequency of drinking alcohol,35790,-0.0596698629143097,0.056410480818607,-0.170234405318779,0.0508946794901601,0.290191429488439
PON2,Serum paraoxonase/arylesterase 2,Lifestyle factors,X29092.Amount of alcohol drunk on a typical drinking day,35203,-0.14611917208682,0.0607039344974692,-0.26509888370186,-0.0271394604717804,0.0161079714427995
PON2,Serum paraoxonase/arylesterase 2,Lifestyle factors,X29093.Frequency of consuming six or more units of alcohol,35222,-0.136486438096356,0.0603250339401718,-0.254723504619092,-0.0182493715736188,0.0236977312253131
PON2,Serum paraoxonase/arylesterase 2,Mental health,X29104.Ever used cannabis,35784,-0.182249084657256,0.0766651984299732,-0.332512873580004,-0.0319852957345087,0.0174703120112846
PON2,Serum paraoxonase/arylesterase 2,Mental health,X29108.Ever thought that life not worth living,35759,0.0983794252862023,0.0763675863841674,-0.0513010440267657,0.24805989459917,0.197705685768402
PON2,Serum paraoxonase/arylesterase 2,Mental health,X29109.Ever contemplated self-harm,35768,-0.0603588276915564,0.10687228749414,-0.26982851118007,0.149110855796957,0.572244288674417
PON2,Serum paraoxonase/arylesterase 2,Mental health,X29111.Ever self-harmed,35777,-0.184132358339365,0.188940575269657,-0.554455885867892,0.186191169189162,0.329815533100289
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X29132.Ever had recurrent episodes of excessive overeating or binge eating,35778,-0.00349359751420902,0.114429599343639,-0.227775612227742,0.220788417199324,0.975644785871271
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X29136#1.Actions and feelings during periods of overeating or binge eating_Eaten much more rapidly than normal,36436,-0.0381084064889571,0.0471348649218899,-0.130492741735861,0.0542759287579471,0.41882895985545
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X29136#2.Actions and feelings during periods of overeating or binge eating_Eaten until feeling uncomfortably full,36436,-0.0585145861726047,0.0361821484521212,-0.129431597138762,0.0124024247935528,0.105870502755303
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X29136#3.Actions and feelings during periods of overeating or binge eating_Eaten large amounts of food when not physically hungry,36436,-0.108498017947679,0.0458771943643949,-0.198417318901893,-0.0185787169934653,0.0180559380057068
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X29136#4.Actions and feelings during periods of overeating or binge eating_Eaten alone because of feeling embarrassed by overeating,36436,0.030030498336977,0.0742631263506136,-0.115525229310226,0.17558622598418,0.685944586081026
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X29149.Dependency of self-esteem on body shape or weight currently,35768,-0.15559042590627,0.0654635323627679,-0.283898949337295,-0.027281902475245,0.0174920447780463
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X29153.Pain or discomfort today,35781,0.101807737707128,0.0595861428881073,-0.0149811023535619,0.218596577767819,0.087571865935848
PON2,Serum paraoxonase/arylesterase 2,Mental health,X29154.Anxiety or depression today,35781,0.116746684231255,0.0796205211093129,-0.039309537142998,0.272802905605509,0.142613410611178
PON2,Serum paraoxonase/arylesterase 2,Mental health,X29166.Frequency of confiding in someone close,35611,-0.0767229952885359,0.0593043600472483,-0.192959540981143,0.0395135504040708,0.195806203566115
PON2,Serum paraoxonase/arylesterase 2,Lifestyle factors,X29167#0.Sports and social activities attended in person at least once a week_None of the above,35764,0.0190363047892884,0.00943844472904956,0.000536953120351284,0.0375356564582256,0.0437442279013941
PON2,Serum paraoxonase/arylesterase 2,Lifestyle factors,X29167#1.Sports and social activities attended in person at least once a week_Sports club or gym or fitness class,35764,-0.0322051317601414,0.00977816295435287,-0.051370331150673,-0.0130399323696098,0.000994011347550544
PON2,Serum paraoxonase/arylesterase 2,Lifestyle factors,X29167#2.Sports and social activities attended in person at least once a week_Pub or social club,35764,-0.00227366165412398,0.0103656716370111,-0.0225903780626657,0.0180430547544178,0.826387303114276
PON2,Serum paraoxonase/arylesterase 2,Lifestyle factors,X29167#3.Sports and social activities attended in person at least once a week_Religious group,35764,-0.0211926870334937,0.0144180844364946,-0.0494521325290231,0.00706675846203569,0.141641306738095
PON2,Serum paraoxonase/arylesterase 2,Lifestyle factors,X29167#4.Sports and social activities attended in person at least once a week_Adult education class,35764,0.0154997122686798,0.0286691016951087,-0.0406917270537334,0.0716911515910929,0.588771368256492
PON2,Serum paraoxonase/arylesterase 2,Lifestyle factors,X29167#5.Sports and social activities attended in person at least once a week_Other group activity,35764,0.00501141807825,0.0105204332301448,-0.0156086310528338,0.0256314672093338,0.633838919444442
PON2,Serum paraoxonase/arylesterase 2,Lifestyle factors,X29168#0.Sports and social activities attended virtually at least once a week_None of the above,35759,-0.00786161067972937,0.0110789072438152,-0.0295762688776072,0.0138530475181484,0.477974316415285
PON2,Serum paraoxonase/arylesterase 2,Lifestyle factors,X29168#1.Sports and social activities attended virtually at least once a week_Sports club or gym or fitness class,35759,-0.0215119021802396,0.0175222829321878,-0.0558555767273277,0.0128317723668485,0.219604355717168
PON2,Serum paraoxonase/arylesterase 2,Lifestyle factors,X29168#2.Sports and social activities attended virtually at least once a week_Pub or social club,35759,0.0114109977691295,0.0198500213757913,-0.0274950441274215,0.0503170396656805,0.565403555195192
PON2,Serum paraoxonase/arylesterase 2,Lifestyle factors,X29168#3.Sports and social activities attended virtually at least once a week_Religious group,35759,-0.012971831271797,0.0244498206771535,-0.0608934797990178,0.0349498172554239,0.595747706068611
PON2,Serum paraoxonase/arylesterase 2,Lifestyle factors,X29168#4.Sports and social activities attended virtually at least once a week_Adult education class,35759,0.0357607646713655,0.0396301826711927,-0.0419143933641722,0.113435922706903,0.366895042092273
PON2,Serum paraoxonase/arylesterase 2,Lifestyle factors,X29168#5.Sports and social activities attended virtually at least once a week_Other group activity,35759,0.0193238981518218,0.0160884106276899,-0.0122093866784503,0.050857182982094,0.229749542058852
PON2,Serum paraoxonase/arylesterase 2,Mental health,X29171.Frequency of feeling 'in tune' with people,35588,-0.0178899556026681,0.0723273083526134,-0.15965147997379,0.123871568768454,0.80464681777702
PON2,Serum paraoxonase/arylesterase 2,Mental health,X29172.Freuency of feeling that lacks companionship,35721,0.0688072210440747,0.0684974567712437,-0.0654477942275629,0.203062236315712,0.315161077300801
PON2,Serum paraoxonase/arylesterase 2,Mental health,X29173.Frequency of feeling left out,35693,0.0588053728912472,0.0706719112422109,-0.0797115731434863,0.197322318925981,0.405386304263746
PON2,Serum paraoxonase/arylesterase 2,Mental health,X29174.Frequency of feeling isolated from others,35725,-0.0826388840747576,0.0723805648496042,-0.224504791179982,0.0592270230304666,0.253605664726813
PON2,Serum paraoxonase/arylesterase 2,Mental health,X29175.Tendency to bounce back quickly after hard times,35774,0.0276545782524527,0.0586915949808754,-0.0873809479100631,0.142690104414968,0.63752321747386
PON2,Serum paraoxonase/arylesterase 2,Mental health,X29176.Ability to make it through stressful events,35774,0.0661450579852806,0.0569046700930499,-0.0453880953970972,0.177678211367658,0.245118345235003
PON2,Serum paraoxonase/arylesterase 2,Mental health,X29177.Quick recovery from stressful events,35774,-0.017003592352183,0.0582840265888617,-0.131240284466352,0.097233099761986,0.770496349013752
PON2,Serum paraoxonase/arylesterase 2,Mental health,X29178.Hard to snap back when something bad happens,35774,0.0389918151246029,0.057355441877341,-0.0734248509549854,0.151408481204191,0.496635542981862
PON2,Serum paraoxonase/arylesterase 2,Mental health,X29179.Comes through difficult times with little trouble,35774,0.0336450094905655,0.0582773785225488,-0.0805786524136301,0.147868671394761,0.563737798655728
PON2,Serum paraoxonase/arylesterase 2,Mental health,X29180.Tendency to take a long time to get over setbacks,35774,-0.0295668687727471,0.0576498870125013,-0.14256064731725,0.0834269097717555,0.608058406960305
PON2,Serum paraoxonase/arylesterase 2,Mental health,X29181.General happiness,35736,0.031287404861276,0.0592490096515429,-0.0848406540557482,0.1474154637783,0.597469754340893
PON2,Serum paraoxonase/arylesterase 2,Mental health,X29182.Belief that own life is meaningful,35637,-0.0639744285891793,0.0603008175341088,-0.182164030956033,0.054215173777674,0.28876204228146
PON2,Serum paraoxonase/arylesterase 2,Lifestyle factors,X2926.Number of unsuccessful stop-smoking attempts,34715,-0.00541173313048068,0.0602800643275998,-0.123560659212576,0.112737192951615,0.928467764559078
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X2946.Father's age,33428,0.0103535534071253,0.00831419479127356,-0.00594226838377093,0.0266493751980214,0.213086940511429
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X2966.Age high blood pressure diagnosed,35379,0.00941734736327436,0.00651724882969054,-0.0033564603429191,0.0221911550694678,0.148507433670221
PON2,Serum paraoxonase/arylesterase 2,Blood and urine assays,X30000.White blood cell (leukocyte) count,51172,0.0276254338517372,0.00277438771137016,0.0221876339374517,0.0330632337660227,2.61761047140488e-23
PON2,Serum paraoxonase/arylesterase 2,Blood and urine assays,X30010.Red blood cell (erythrocyte) count,51173,0.0428846932246068,0.00297883548624241,0.0370461756715716,0.0487232107776419,8.77848269336914e-47
PON2,Serum paraoxonase/arylesterase 2,Blood and urine assays,X30020.Haemoglobin concentration,51173,0.0461228230864491,0.00313193495796194,0.0399842305688437,0.0522614156040546,7.3325912184671e-49
PON2,Serum paraoxonase/arylesterase 2,Blood and urine assays,X30030.Haematocrit percentage,51173,0.043908585834233,0.0030766899310145,0.0378782735694446,0.0499388980990214,5.23386345262427e-46
PON2,Serum paraoxonase/arylesterase 2,Blood and urine assays,X30040.Mean corpuscular volume,51173,-0.00803712566849814,0.00275332684355423,-0.0134336462818644,-0.00264060505513186,0.00351435641721096
PON2,Serum paraoxonase/arylesterase 2,Blood and urine assays,X30050.Mean corpuscular haemoglobin,51173,-0.0063142391730492,0.00276521044091393,-0.0117340516372405,-0.000894426708857899,0.0224127102827765
PON2,Serum paraoxonase/arylesterase 2,Blood and urine assays,X30060.Mean corpuscular haemoglobin concentration,51173,0.00043720190233797,0.00268832178368934,-0.00483190879369313,0.00570631259836907,0.870811182325995
PON2,Serum paraoxonase/arylesterase 2,Blood and urine assays,X30070.Red blood cell (erythrocyte) distribution width,51173,0.0107996208358462,0.00281368070353503,0.00528480665691753,0.0163144350147749,0.000124250065035766
PON2,Serum paraoxonase/arylesterase 2,Blood and urine assays,X30080.Platelet count,51173,0.0304881635058641,0.00274392691147551,0.0251100667593721,0.0358662602523561,1.31372078135954e-28
PON2,Serum paraoxonase/arylesterase 2,Blood and urine assays,X30090.Platelet crit,51173,0.0290836848150096,0.00279355102765495,0.0236083248008059,0.0345590448292133,2.5205549983568e-25
PON2,Serum paraoxonase/arylesterase 2,Blood and urine assays,X30100.Mean platelet (thrombocyte) volume,51173,-0.0118116177693083,0.00260412134770385,-0.0169156956108078,-0.00670753992780873,5.76971753920041e-06
PON2,Serum paraoxonase/arylesterase 2,Blood and urine assays,X30110.Platelet distribution width,51173,0.0115637569043618,0.00267362348444034,0.00632345487485869,0.0168040589338648,1.53098966712485e-05
PON2,Serum paraoxonase/arylesterase 2,Blood and urine assays,X30120.Lymphocyte count,51135,0.0141415880616457,0.00269992723079904,0.00884973068927956,0.0194334454340118,1.63991598711068e-07
PON2,Serum paraoxonase/arylesterase 2,Blood and urine assays,X30130.Monocyte count,51135,0.0218416226946112,0.00270715000324489,0.0165356086882513,0.0271476367009712,7.49226990951954e-16
PON2,Serum paraoxonase/arylesterase 2,Blood and urine assays,X30140.Neutrophill count,51135,0.0225439681462652,0.00274484129394238,0.0171640792101381,0.0279238570823923,2.26809593055921e-16
PON2,Serum paraoxonase/arylesterase 2,Blood and urine assays,X30150.Eosinophill count,51135,0.00883504852829352,0.0026166467641278,0.00370642087060303,0.013963676185984,0.000735444525514385
PON2,Serum paraoxonase/arylesterase 2,Blood and urine assays,X30160.Basophill count,51135,0.0647183053940462,0.0348317434445897,-0.00355191175734966,0.132988522545442,0.0631782713595148
PON2,Serum paraoxonase/arylesterase 2,Blood and urine assays,X30170.Nucleated red blood cell count,51135,0.301783524568812,0.168287726721647,-0.0280604198056174,0.63162746894324,0.0729448831454454
PON2,Serum paraoxonase/arylesterase 2,Blood and urine assays,X30180.Lymphocyte percentage,51136,-0.00695193637418281,0.00267502382571405,-0.0121949830725823,-0.00170888967578327,0.00936025782444918
PON2,Serum paraoxonase/arylesterase 2,Blood and urine assays,X30190.Monocyte percentage,51136,0.00318147159625836,0.00268241710478017,-0.00207606592911078,0.0084390091216275,0.235616414755214
PON2,Serum paraoxonase/arylesterase 2,Blood and urine assays,X30200.Neutrophill percentage,51136,0.00433549978915318,0.00263996412493505,-0.000838829895719516,0.00950982947402588,0.100550689008407
PON2,Serum paraoxonase/arylesterase 2,Blood and urine assays,X30210.Eosinophill percentage,51136,0.000906541597376711,0.00259295902982413,-0.00417565810107858,0.00598874129583201,0.726629695710584
PON2,Serum paraoxonase/arylesterase 2,Blood and urine assays,X30220.Basophill percentage,51136,0.000566207930966725,0.0027144588413082,-0.00475413139799734,0.00588654725993079,0.834770501596008
PON2,Serum paraoxonase/arylesterase 2,Blood and urine assays,X30230.Nucleated red blood cell percentage,51134,0.300828280563251,0.16866007359478,-0.029745463682518,0.63140202480902,0.0744961883429576
PON2,Serum paraoxonase/arylesterase 2,Blood and urine assays,X30240.Reticulocyte percentage,50794,0.0315146935115109,0.00285546792141632,0.0259179763855349,0.0371114106374869,3.01367416024873e-28
PON2,Serum paraoxonase/arylesterase 2,Blood and urine assays,X30250.Reticulocyte count,50794,0.0398480648626478,0.00287528110240368,0.0342125139019366,0.045483615823359,1.70747543111306e-43
PON2,Serum paraoxonase/arylesterase 2,Blood and urine assays,X30260.Mean reticulocyte volume,50794,-0.00141112022748726,0.00270681374565436,-0.00671647516896982,0.00389423471399529,0.602148021179696
PON2,Serum paraoxonase/arylesterase 2,Blood and urine assays,X30270.Mean sphered cell volume,50794,-0.00797972037895478,0.00272639486978336,-0.0133234543237302,-0.00263598643417941,0.00342772795750113
PON2,Serum paraoxonase/arylesterase 2,Blood and urine assays,X30280.Immature reticulocyte fraction,50794,0.0184454792273367,0.00281128610333682,0.0129353584647966,0.0239555999898769,5.45443486874588e-11
PON2,Serum paraoxonase/arylesterase 2,Blood and urine assays,X30290.High light scatter reticulocyte percentage,50794,0.0329751785908005,0.00289198876306246,0.0273068806151981,0.038643476566403,4.93977427543605e-30
PON2,Serum paraoxonase/arylesterase 2,Blood and urine assays,X30300.High light scatter reticulocyte count,50794,0.0396365156612059,0.00289894007403528,0.0339545931160967,0.0453184382063151,2.1936138916932e-42
PON2,Serum paraoxonase/arylesterase 2,Blood and urine assays,X30500.Microalbumin in urine,36881,0.0179625342907808,0.00431387899509262,0.00950733146039923,0.0264177371211623,3.16037703817303e-05
PON2,Serum paraoxonase/arylesterase 2,Blood and urine assays,X30510.Creatinine (enzymatic) in urine,51229,0.0105692436606901,0.00291178913157594,0.00486213696280124,0.0162763503585789,0.000284254090935676
PON2,Serum paraoxonase/arylesterase 2,Blood and urine assays,X30520.Potassium in urine,51183,0.00817498365094839,0.00271871004959138,0.00284631195374928,0.0135036553481475,0.00264186682130359
PON2,Serum paraoxonase/arylesterase 2,Blood and urine assays,X30530.Sodium in urine,51195,0.0179436602435689,0.00281104419763994,0.0124340136161947,0.0234533068709432,1.76710676861962e-10
PON2,Serum paraoxonase/arylesterase 2,Blood and urine assays,X30600.Albumin,49065,0.00532983490820316,0.00287269073829435,-0.000300638938853767,0.0109603087552601,0.0635612200319279
PON2,Serum paraoxonase/arylesterase 2,Blood and urine assays,X30610.Alkaline phosphatase,50753,0.0213323192283116,0.00282014951281721,0.0158048261831899,0.0268598122734333,4.05280532566084e-14
PON2,Serum paraoxonase/arylesterase 2,Blood and urine assays,X30620.Alanine aminotransferase,50739,0.0560201878932431,0.00303061029049334,0.0500801917238762,0.0619601840626101,1.01731130035442e-75
PON2,Serum paraoxonase/arylesterase 2,Blood and urine assays,X30630.Apolipoprotein A,49002,-0.00680736464143609,0.00310622678683814,-0.0128955691436389,-0.000719160139233334,0.0284252967373921
PON2,Serum paraoxonase/arylesterase 2,Blood and urine assays,X30640.Apolipoprotein B,50594,0.0421265111988739,0.00263540295870478,0.0369611213998126,0.0472919009979353,3.42316245622459e-57
PON2,Serum paraoxonase/arylesterase 2,Blood and urine assays,X30650.Aspartate aminotransferase,50676,0.0378732738315079,0.00280690816964508,0.0323717338190035,0.0433748138440122,2.51208494596623e-41
PON2,Serum paraoxonase/arylesterase 2,Blood and urine assays,X30660.Direct bilirubin,49219,-0.00342616575530566,0.00288464503548581,-0.00908007002485784,0.00222773851424652,0.23495535279114
PON2,Serum paraoxonase/arylesterase 2,Blood and urine assays,X30670.Urea,50736,-0.0138787336178975,0.0027641898832005,-0.0192965457889704,-0.00846092144682447,5.182792318846e-07
PON2,Serum paraoxonase/arylesterase 2,Blood and urine assays,X30680.Calcium,49056,0.0193538633425093,0.00284150530984717,0.0137845129352089,0.0249232137498098,9.95232327945059e-12
PON2,Serum paraoxonase/arylesterase 2,Blood and urine assays,X30690.Cholesterol,50757,0.0383569947414566,0.00265908076363475,0.0331451964447325,0.0435687930381807,5.88946164941003e-47
PON2,Serum paraoxonase/arylesterase 2,Blood and urine assays,X30700.Creatinine,50745,-0.0134154134781603,0.00344657328695725,-0.0201706971205965,-0.00666012983572412,9.95515370928413e-05
PON2,Serum paraoxonase/arylesterase 2,Blood and urine assays,X30710.C-reactive protein,50676,0.0577668886515425,0.00293001292345961,0.0520240633215616,0.0635097139815233,8.67582686381698e-86
PON2,Serum paraoxonase/arylesterase 2,Blood and urine assays,X30720.Cystatin C,50760,0.0479142363523757,0.00317679577627186,0.0416877166308828,0.0541407560738685,3.78551264400438e-51
PON2,Serum paraoxonase/arylesterase 2,Blood and urine assays,X30730.Gamma glutamyltransferase,50740,0.0709392338548225,0.00317705505414151,0.0647122059487051,0.0771662617609399,3.13022331098521e-109
PON2,Serum paraoxonase/arylesterase 2,Blood and urine assays,X30740.Glucose,49033,0.00569391206275019,0.00270532941859358,0.000391466402306772,0.0109963577231936,0.0353294412669795
PON2,Serum paraoxonase/arylesterase 2,Blood and urine assays,X30750.Glycated haemoglobin (HbA1c),50644,0.0127080363376843,0.00273237480989232,0.00735258171029536,0.0180634909650732,3.32386770252112e-06
PON2,Serum paraoxonase/arylesterase 2,Blood and urine assays,X30760.HDL cholesterol,49042,-0.0253460596468588,0.00320793072751786,-0.0316336038727938,-0.0190585154209238,2.90447271900063e-15
PON2,Serum paraoxonase/arylesterase 2,Blood and urine assays,X30770.IGF-1,50650,-0.03861430577385,0.00281294949141922,-0.0441276867770317,-0.0331009247706684,1.04376189289443e-42
PON2,Serum paraoxonase/arylesterase 2,Blood and urine assays,X30780.LDL direct,50705,0.0394548036075528,0.00265261067044921,0.0342556866934723,0.0446539205216332,8.47405166542026e-50
PON2,Serum paraoxonase/arylesterase 2,Blood and urine assays,X30790.Lipoprotein A,46265,-0.00835202052598477,0.00292637511244136,-0.0140877157463698,-0.00261632530559971,0.00432159615682062
PON2,Serum paraoxonase/arylesterase 2,Blood and urine assays,X30810.Phosphate,49002,-0.00105484459305971,0.0027748162653495,-0.00649348447314473,0.00438379528702531,0.703838513693382
PON2,Serum paraoxonase/arylesterase 2,Blood and urine assays,X30830.SHBG,48909,-0.00143858855520812,0.00369004298361405,-0.00867107280309166,0.00579389569267543,0.69664648691405
PON2,Serum paraoxonase/arylesterase 2,Blood and urine assays,X30840.Total bilirubin,50662,-0.000475725572432692,0.00290835913716077,-0.00617610948126781,0.00522465833640242,0.870069735275215
PON2,Serum paraoxonase/arylesterase 2,Blood and urine assays,X30850.Testosterone,50529,0.0139122759029357,0.00456405676712308,0.00496672463937451,0.022857827166497,0.00230470910084515
PON2,Serum paraoxonase/arylesterase 2,Blood and urine assays,X30860.Total protein,49032,0.0291265896105313,0.00280932168231671,0.0236203191131906,0.0346328601078721,4.00885078568714e-25
PON2,Serum paraoxonase/arylesterase 2,Blood and urine assays,X30870.Triglycerides,50730,0.0511909311312316,0.00277366533875069,0.0457545470672802,0.0566273151951829,1.7190813671692e-75
PON2,Serum paraoxonase/arylesterase 2,Blood and urine assays,X30880.Urate,50724,0.028161456881913,0.00333590207700089,0.0216230888109913,0.0346998249528348,3.31061979510909e-17
PON2,Serum paraoxonase/arylesterase 2,Blood and urine assays,X30890.Vitamin D,50096,-0.030198759733247,0.00299689504903939,-0.0360726740293642,-0.0243248454371297,7.91313280202056e-24
PON2,Serum paraoxonase/arylesterase 2,Physical measures,X3137.Number of measurements made,49482,0.0230881287808316,0.0421005301253233,-0.0594289102648021,0.105605167826465,0.583419909798097
PON2,Serum paraoxonase/arylesterase 2,Physical measures,X3143.Ankle spacing width,41775,0.0028645820327767,0.00485024337748962,-0.00664189498710296,0.0123710590526564,0.554794685797927
PON2,Serum paraoxonase/arylesterase 2,Physical measures,"X3144.Heel Broadband ultrasound attenuation, direct entry",41774,-0.00829771329572973,0.00353156895273558,-0.0152195884430915,-0.001375838148368,0.0188091486526407
PON2,Serum paraoxonase/arylesterase 2,Physical measures,X3146.Speed of sound through heel,41775,-0.00839123172044458,0.00340928932481646,-0.0150734387970849,-0.00170902464380432,0.0138567680473083
PON2,Serum paraoxonase/arylesterase 2,Physical measures,"X3147.Heel quantitative ultrasound index (QUI), direct entry",41775,-0.00856648940393071,0.00344215228609418,-0.0153131078846753,-0.00181987092318611,0.0128333094430945
PON2,Serum paraoxonase/arylesterase 2,Physical measures,X3148.Heel bone mineral density (BMD),41756,-0.00942852627971063,0.00346061065663868,-0.0162113231667224,-0.00264572939269881,0.00644787806997605
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X3526.Mother's age at death,42489,-0.00206292244331115,0.00351114275395087,-0.00894476224105486,0.00481891735443255,0.556853393483306
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,"X3761.Age hay fever, rhinitis or eczema diagnosed",32877,-0.00668514569245901,0.00616285760377438,-0.0187643465958568,0.00539405521093878,0.278094549120828
PON2,Serum paraoxonase/arylesterase 2,Physical measures,X4100.Ankle spacing width (left),36049,0.00271641574370708,0.00647744532707491,-0.00997937709735975,0.0154122085847739,0.674961279612989
PON2,Serum paraoxonase/arylesterase 2,Physical measures,X4101.Heel broadband ultrasound attenuation (left),36047,-0.00413008628260629,0.00470115015325347,-0.0133443405829831,0.00508416801777052,0.379686258014227
PON2,Serum paraoxonase/arylesterase 2,Physical measures,X4103.Speed of sound through heel (left),36049,-0.0046889339279346,0.00449768938823699,-0.0135044051288791,0.00412653727300991,0.2972042034105
PON2,Serum paraoxonase/arylesterase 2,Physical measures,"X4104.Heel quantitative ultrasound index (QUI), direct entry (left)",36049,-0.0048103127615782,0.00456109222360157,-0.0137500535198373,0.00412942799668089,0.291623961161704
PON2,Serum paraoxonase/arylesterase 2,Physical measures,X4105.Heel bone mineral density (BMD) (left),36039,-0.00482001487920175,0.00458394768295585,-0.0138045523377952,0.00416452257939172,0.293063776378896
PON2,Serum paraoxonase/arylesterase 2,Physical measures,"X4106.Heel bone mineral density (BMD) T-score, automated (left)",36049,-0.00481271913561633,0.00456138446543719,-0.0137530326878732,0.00412759441664056,0.291413572249961
PON2,Serum paraoxonase/arylesterase 2,Physical measures,X4119.Ankle spacing width (right),36037,0.000803708970772256,0.0063584672461435,-0.011658886831669,0.0132663047732135,0.899418879559634
PON2,Serum paraoxonase/arylesterase 2,Physical measures,X4120.Heel broadband ultrasound attenuation (right),36036,0.00143405165221331,0.0047408667817086,-0.00785804723993555,0.0107261505443622,0.762289128600152
PON2,Serum paraoxonase/arylesterase 2,Physical measures,X4122.Speed of sound through heel (right),36037,0.000547643037169123,0.00449837371842566,-0.00826916945094517,0.00936445552528342,0.903106282264454
PON2,Serum paraoxonase/arylesterase 2,Physical measures,"X4123.Heel quantitative ultrasound index (QUI), direct entry (right)",36037,0.000974933993966123,0.00457655852007867,-0.00799512070538807,0.00994498869332031,0.831311151901485
PON2,Serum paraoxonase/arylesterase 2,Physical measures,X4124.Heel bone mineral density (BMD) (right),36026,-0.000291116235370631,0.00460001103265536,-0.00930713785937514,0.00872490538863388,0.949540477976973
PON2,Serum paraoxonase/arylesterase 2,Physical measures,"X4125.Heel bone mineral density (BMD) T-score, automated (right)",36037,0.000972387075478409,0.00457656235063742,-0.00799767513177094,0.00994244928272775,0.831745372442712
PON2,Serum paraoxonase/arylesterase 2,Physical measures,X4194.Pulse rate,36412,0.0370856208218841,0.00424853646371042,0.0287584893530117,0.0454127522907566,3.10424214883424e-18
PON2,Serum paraoxonase/arylesterase 2,Physical measures,X4195.Pulse wave reflection index,36412,-0.00423445356518169,0.00448285621367414,-0.013020851743983,0.00455194461361963,0.344898311515575
PON2,Serum paraoxonase/arylesterase 2,Physical measures,X4196.Pulse wave peak to peak time,36404,-0.0261294336017162,0.00492963879948074,-0.0357915256486985,-0.0164673415547339,1.18661679081877e-07
PON2,Serum paraoxonase/arylesterase 2,Physical measures,X4198.Position of the pulse wave peak,36412,0.0322097639405002,0.0053313537382759,0.0217603106134795,0.042659217267521,1.59612843970451e-09
PON2,Serum paraoxonase/arylesterase 2,Physical measures,X4199.Position of pulse wave notch,36412,0.0200163171190609,0.00432855415564509,0.0115323509739965,0.0285002832641253,3.82000665715026e-06
PON2,Serum paraoxonase/arylesterase 2,Physical measures,X4200.Position of the shoulder on the pulse waveform,36412,0.0364118625686911,0.00542261149316027,0.025783544042097,0.0470401810952852,2.01479329017071e-11
PON2,Serum paraoxonase/arylesterase 2,Physical measures,X4269.Number of triplets attempted (left),36195,-0.430454043880197,0.172172516505487,-0.767912176230951,-0.0929959115294435,0.0124356552533077
PON2,Serum paraoxonase/arylesterase 2,Physical measures,X4270.Volume level set by participant (left),36109,0.0394071717344443,0.0540617535065847,-0.0665538651384617,0.14536820860735,0.466067929490437
PON2,Serum paraoxonase/arylesterase 2,Physical measures,X4276.Number of triplets attempted (right),36198,-0.388195817508295,0.170945952710337,-0.723249884820556,-0.0531417501960337,0.0231828358632902
PON2,Serum paraoxonase/arylesterase 2,Physical measures,X4277.Volume level set by participant (right),36110,-0.00866671468456547,0.0540796537736754,-0.114662836080969,0.0973294067118384,0.872681898846138
PON2,Serum paraoxonase/arylesterase 2,Cognitive function,X4288.Time to answer,36377,-0.00451910674322506,0.00510067280953794,-0.0145164254499194,0.00547821196346931,0.375654362539289
PON2,Serum paraoxonase/arylesterase 2,Cognitive function,X4290.Duration screen displayed,36377,-0.000654672283013572,0.0047692282376981,-0.0100023596289018,0.0086930150628747,0.890820882430606
PON2,Serum paraoxonase/arylesterase 2,Physical measures,X46.Hand grip strength (left),51764,-0.0116022436867504,0.0035425924987788,-0.0185457249843569,-0.00465876238914397,0.00105790294329008
PON2,Serum paraoxonase/arylesterase 2,Physical measures,X47.Hand grip strength (right),51767,-0.0128618857770282,0.00349322457749535,-0.019708605948919,-0.00601516560513728,0.00023198046292138
PON2,Serum paraoxonase/arylesterase 2,Physical measures,X48.Waist circumference,51824,0.061386718737771,0.0066096763097306,0.0484317531706991,0.074341684304843,1.71566025097553e-20
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X4803.Tinnitus,36228,0.0266239210690758,0.0619998265574079,-0.0948957389834438,0.148143581121595,0.667630256275804
PON2,Serum paraoxonase/arylesterase 2,Working and living environment,X4825.Noisy workplace,36305,0.171398170250804,0.0593081583363672,0.0551541799115242,0.287642160590083,0.00386367369598
PON2,Serum paraoxonase/arylesterase 2,Working and living environment,X4836.Loud music exposure frequency,36256,0.156070551151444,0.0787642815826103,0.00169255924952735,0.31044854305336,0.0475721934884022
PON2,Serum paraoxonase/arylesterase 2,Physical measures,X49.Hip circumference,51818,-0.0121476325698657,0.00488742342481729,-0.0217269824825076,-0.00256828265722385,0.0129443755463064
PON2,Serum paraoxonase/arylesterase 2,Physical measures,X50.Standing height,51776,-0.0121113241628396,0.00369322744279762,-0.0193500499507229,-0.00487259837495622,0.00104206011550974
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X5057.Number of older siblings,35384,0.057416991660955,0.0575711940327858,-0.0554225486433052,0.170256531965215,0.318644039686332
PON2,Serum paraoxonase/arylesterase 2,Physical measures,X51.Seated height,51677,-0.0089460286583116,0.0032184305774243,-0.0152541525900632,-0.00263790472655997,0.00544658191863529
PON2,Serum paraoxonase/arylesterase 2,Eye measures,X5181.Ever had eye surgery,33829,-0.0192233604134462,0.130804876619393,-0.275600918587456,0.237154197760564,0.88316759666676
PON2,Serum paraoxonase/arylesterase 2,Eye measures,X5186.Duration visual-acuity screen displayed (right),33819,0.00400267542676558,0.00553536601676009,-0.00684664196608419,0.0148519928196154,0.469645053849163
PON2,Serum paraoxonase/arylesterase 2,Eye measures,X5188.Duration visual-acuity screen displayed (left),33814,0.0119873956984984,0.00572042251974179,0.000775367559804497,0.0231994238371923,0.0361707890979082
PON2,Serum paraoxonase/arylesterase 2,Eye measures,X5190.Duration at which refractometer first shown (right),33765,0.010835177112353,0.00572754142438927,-0.000390804079449997,0.0220611583041559,0.0585778450490732
PON2,Serum paraoxonase/arylesterase 2,Eye measures,X5193.Duration at which refractometer first shown (left),33760,0.0106251535621863,0.00575571021457045,-0.000656038458371823,0.0219063455827443,0.0649466085843654
PON2,Serum paraoxonase/arylesterase 2,Eye measures,"X5199.logMAR, initial (right)",33798,0.049268766852037,0.0676690198307526,-0.0833625120162381,0.181900045720312,0.466594642163214
PON2,Serum paraoxonase/arylesterase 2,Eye measures,X5200.Final number of letters displayed (right),33798,0.186184224815377,0.408335285090577,-0.614152933962154,0.986521383592908,0.64843838169017
PON2,Serum paraoxonase/arylesterase 2,Eye measures,"X5201.logMAR, final (right)",33736,-0.000103647666638614,0.00548857696825811,-0.0108612585244245,0.0106539631911473,0.984934176496253
PON2,Serum paraoxonase/arylesterase 2,Eye measures,X5202.Number of rounds to result (right),33798,0.114140468070482,0.0638124583653689,-0.010931950325641,0.239212886466605,0.0737236934356451
PON2,Serum paraoxonase/arylesterase 2,Eye measures,"X5206.logMAR, initial (left)",33792,-0.00436539561287539,0.0672149521834542,-0.136106701892446,0.127375910666695,0.948218864321246
PON2,Serum paraoxonase/arylesterase 2,Eye measures,X5207.Final number of letters displayed (left),33792,-0.916543743735874,0.393579898389589,-1.68796034457947,-0.145127142892279,0.0199112511141063
PON2,Serum paraoxonase/arylesterase 2,Eye measures,"X5208.logMAR, final (left)",33745,-0.00334096593861747,0.00553881790531983,-0.0141970490330443,0.00751511715580939,0.546408123217368
PON2,Serum paraoxonase/arylesterase 2,Eye measures,X5209.Number of rounds to result (left),33788,0.033287599352177,0.0635541472203514,-0.0912785291997118,0.157853727904066,0.600462653034936
PON2,Serum paraoxonase/arylesterase 2,Eye measures,"X5254.Intra-ocular pressure, corneal-compensated (right)",33598,0.00651753350240488,0.00548168366682497,-0.00422656648457206,0.0172616334893818,0.234509675237135
PON2,Serum paraoxonase/arylesterase 2,Eye measures,"X5255.Intra-ocular pressure, Goldmann-correlated (right)",33598,0.00440776251420221,0.00537686440400526,-0.00613089171764809,0.0149464167460525,0.412389467312092
PON2,Serum paraoxonase/arylesterase 2,Eye measures,X5256.Corneal hysteresis (right),33598,-0.00502035775774573,0.00556592811185383,-0.0159295768569792,0.00588886134148778,0.367110772973665
PON2,Serum paraoxonase/arylesterase 2,Eye measures,X5257.Corneal resistance factor (right),33598,-0.000900167576065893,0.00548651611620395,-0.0116537391638256,0.00985340401169384,0.869683407578249
PON2,Serum paraoxonase/arylesterase 2,Eye measures,"X5262.Intra-ocular pressure, corneal-compensated (left)",33572,-0.00237261790313846,0.00550610193271718,-0.0131645776912641,0.00841934188498722,0.666554668081727
PON2,Serum paraoxonase/arylesterase 2,Eye measures,"X5263.Intra-ocular pressure, Goldmann-correlated (left)",33572,0.00577048434695009,0.00545991868408096,-0.00493095627384858,0.0164719249677488,0.290617246018919
PON2,Serum paraoxonase/arylesterase 2,Eye measures,X5264.Corneal hysteresis (left),33572,0.0113127598301025,0.00548499791042985,0.000562163925659989,0.022063355734545,0.0392128235355297
PON2,Serum paraoxonase/arylesterase 2,Eye measures,X5265.Corneal resistance factor (left),33572,0.01309840408916,0.00545793407691461,0.00240085329840739,0.0237959548799127,0.016436862589074
PON2,Serum paraoxonase/arylesterase 2,Lifestyle factors,X5364.Average weekly intake of other alcoholic drinks,34492,0.267625253870361,0.300813321939326,-0.321968857130717,0.857219364871439,0.373678247137435
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,"X6144#1.Never eat eggs, dairy, wheat, sugar_Eggs or foods containing eggs",51755,-0.0113761306104548,0.0144990979678976,-0.0397943626275342,0.0170421014066246,0.432690560787032
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,"X6144#2.Never eat eggs, dairy, wheat, sugar_Dairy products",51755,-0.0150595721916534,0.0168763477278341,-0.0481372137382083,0.0180180693549015,0.372215800638324
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,"X6144#3.Never eat eggs, dairy, wheat, sugar_Wheat products",51755,-0.0538870816598666,0.0410118306550138,-0.134270269743694,0.0264961064239604,0.188879438904021
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,"X6144#4.Never eat eggs, dairy, wheat, sugar_Sugar or foods or drinks containing sugar",51755,-0.0312898896546184,0.00658065010248849,-0.0441879638554959,-0.018391815453741,1.99805187949579e-06
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,"X6144#5.Never eat eggs, dairy, wheat, sugar_I eat all of the above",51755,0.0233687524660596,0.00610488215360075,0.0114031834450021,0.035334321487117,0.000129592000618093
PON2,Serum paraoxonase/arylesterase 2,Mental health,"X6145#3.Illness, injury, bereavement, stress in last 2 years_Death of a close relative",38731,0.00334742976242017,0.00785268886734171,-0.0120438404175696,0.0187386999424099,0.669914226735003
PON2,Serum paraoxonase/arylesterase 2,Mental health,"X6145#4.Illness, injury, bereavement, stress in last 2 years_Death of a spouse or partner",38731,-0.00220832940447518,0.0244467154130428,-0.050123891614039,0.0457072328050887,0.928024894483568
PON2,Serum paraoxonase/arylesterase 2,Mental health,"X6145#5.Illness, injury, bereavement, stress in last 2 years_Marital separation or divorce",38731,0.000508223070552127,0.0152283280374763,-0.0293392998829014,0.0303557460240056,0.973377374939746
PON2,Serum paraoxonase/arylesterase 2,Mental health,"X6145#6.Illness, injury, bereavement, stress in last 2 years_Financial difficulties",38731,0.0171600887423565,0.00911343923919418,-0.00070225216646411,0.0350224296511771,0.0597366876887891
PON2,Serum paraoxonase/arylesterase 2,Eye measures,X6147#1.Reason for glasses or contact lenses_For short-sightedness,51823,0.00668695884799801,0.0139732341914216,-0.0207005801671883,0.0340744978631843,0.632259857427877
PON2,Serum paraoxonase/arylesterase 2,Eye measures,X6147#2.Reason for glasses or contact lenses_For long-sightedness,51823,0.00668695884799801,0.0139732341914216,-0.0207005801671883,0.0340744978631843,0.632259857427877
PON2,Serum paraoxonase/arylesterase 2,Eye measures,X6147#3.Reason for glasses or contact lenses_For just reading or near work as you are getting older (called 'presbyopia'),51823,0.0251161365491649,0.0101674634070404,0.00518790827136565,0.0450443648269642,0.0135091436443101
PON2,Serum paraoxonase/arylesterase 2,Eye measures,X6147#4.Reason for glasses or contact lenses_For 'astigmatism',51823,-0.027029050990802,0.0179477761299577,-0.0622066922055191,0.00814859022391506,0.132085063699254
PON2,Serum paraoxonase/arylesterase 2,Eye measures,X6147#5.Reason for glasses or contact lenses_For a 'squint' or 'turn' in an eye since childhood (called 'strabismus'),51823,0.0239734002850883,0.0412674857758418,-0.0569108718355616,0.104857672405738,0.561295233364253
PON2,Serum paraoxonase/arylesterase 2,Eye measures,X6147#6.Reason for glasses or contact lenses_For a 'lazy' eye or an eye with poor vision since childhood (called 'amblyopia'),51823,0.0155965355879019,0.0299121594694654,-0.0430312969722503,0.074224368148054,0.602085308586881
PON2,Serum paraoxonase/arylesterase 2,Eye measures,X6147#7.Reason for glasses or contact lenses_Other eye condition,51823,0.0686887163310472,0.0440278322976814,-0.0176058349724084,0.154983267634503,0.118745074164014
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X6149#1.Mouth or teeth dental problems_Mouth ulcers,51754,-0.00259617557994572,0.00903219863406874,-0.0202992849027205,0.015106933742829,0.773781365786452
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X6149#2.Mouth or teeth dental problems_Painful gums,51754,0.000246582289307881,0.0159389576569313,-0.0309937747182775,0.0314869392968933,0.987657020386249
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X6149#3.Mouth or teeth dental problems_Bleeding gums,51754,0.029745733854977,0.00823884836820175,0.0135975910533016,0.0458938766566525,0.000306342485992558
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X6149#4.Mouth or teeth dental problems_Loose teeth,51754,0.0306701882939092,0.0122443852647119,0.0066711931750738,0.0546691834127445,0.0122576009482614
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X6149#5.Mouth or teeth dental problems_Toothache,51754,0.00767729734402973,0.0123188420267591,-0.0164676330284182,0.0318222277164776,0.533148839801343
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X6149#6.Mouth or teeth dental problems_Dentures,51754,0.0244315150356961,0.00695159093912923,0.0108063967950028,0.0380566332763894,0.000441388113318721
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X6150#1.Vascular or heart problems diagnosed by doctor_Heart attack,36969,-0.0248618948759296,0.013150216312806,-0.0506363188490293,0.00091252909717008,0.0587112989843383
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X6150#2.Vascular or heart problems diagnosed by doctor_Angina,36969,-0.0480544408470598,0.0124744507448428,-0.0725043643069518,-0.0236045173871679,0.000117921238016067
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X6150#3.Vascular or heart problems diagnosed by doctor_Stroke,36969,0.00344485459403702,0.0180559030534195,-0.0319447153906652,0.0388344245787392,0.848696103082016
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X6150#4.Vascular or heart problems diagnosed by doctor_High blood pressure,36969,0.0341863984762422,0.0135131958229538,0.00770053466325276,0.0606722622892317,0.0114292265153246
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X6151#1.Fractured bone site(s)_Ankle,51701,0.039145080779916,0.0242208085251632,-0.00832770392940397,0.0866178654892359,0.106069998484579
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X6151#2.Fractured bone site(s)_Leg,51701,0.113268859528779,0.0304136914392322,0.0536580243078839,0.172879694749674,0.000196345315517547
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X6151#3.Fractured bone site(s)_Hip,51701,0.0970702308636293,0.0605151638920579,-0.0215394903648042,0.215679952092063,0.108713488988139
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X6151#4.Fractured bone site(s)_Spine,51701,-0.00749129872124236,0.0578039779126683,-0.120787095430072,0.105804497987587,0.896885356774812
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X6151#5.Fractured bone site(s)_Wrist,51701,0.0423983493754063,0.0229553894850802,-0.00259421401535084,0.0873909127661635,0.0647615300021232
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X6151#6.Fractured bone site(s)_Arm,51701,-0.00432893008377232,0.0272875908739536,-0.0578126081967213,0.0491547480291766,0.873953129125114
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X6151#7.Fractured bone site(s)_Other bones,51701,0.00429835201120454,0.0114157974733309,-0.0180766110365239,0.026673315058933,0.706528862916248
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,"X6152#5.Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor_Blood clot in the leg (DVT)",35522,-0.0192069475667743,0.019456104972677,-0.0573409133132213,0.0189270181796727,0.323582111307291
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,"X6152#6.Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor_Emphysema or chronic bronchitis",35522,0.0276668432119609,0.0190154277661161,-0.0096033952096266,0.0649370816335484,0.145723403004538
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,"X6152#7.Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor_Blood clot in the lung",35522,-0.0274792845395899,0.0267596188129853,-0.079928137413041,0.0249695683338613,0.304506393672652
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,"X6152#8.Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor_Asthma",35522,0.0208898257426946,0.00975644599424112,0.00176719159398201,0.0400124598914072,0.0322983219088379
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,"X6154#1.Medication for pain relief, constipation, heartburn_Aspirin",38617,-0.0297770344483702,0.00840661874524557,-0.0462540071890515,-0.0133000617076888,0.00039876871426548
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,"X6154#2.Medication for pain relief, constipation, heartburn_Ibuprofen",38617,0.0179770992143467,0.00929580797682333,-0.000242684420227002,0.0361968828489204,0.0531544033883349
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,"X6154#3.Medication for pain relief, constipation, heartburn_Paracetamol",38617,0.0205136960846725,0.00824476061006233,0.00435396528895037,0.0366734268803947,0.0128592969945487
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,"X6154#4.Medication for pain relief, constipation, heartburn_Ranitidine",38618,0.00555856393122336,0.0190287329248679,-0.0317377526015177,0.0428548804639644,0.770205325279351
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,"X6154#5.Medication for pain relief, constipation, heartburn_Omeprazole",38618,0.0280147507591543,0.0114397655192143,0.0055928103414944,0.0504366911768143,0.0143466539867073
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,"X6154#6.Medication for pain relief, constipation, heartburn_Laxatives",38618,-0.051641554009708,0.0208097629174516,-0.0924286893279131,-0.0108544186915028,0.0130955921047178
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X6155#1.Vitamin and mineral supplements_Vitamin A,51754,-0.0319787800946908,0.0178576754052352,-0.0669798238889517,0.00302226369957018,0.073345151378635
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X6155#2.Vitamin and mineral supplements_Vitamin B,51754,-0.00889169289938672,0.0143909063002886,-0.0370978692479524,0.019314483449179,0.536667862996343
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X6155#3.Vitamin and mineral supplements_Vitamin C,51754,-0.0105748442077023,0.0283657600337856,-0.066171733873922,0.0450220454585174,0.709298383429212
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X6155#4.Vitamin and mineral supplements_Vitamin D,51754,-0.00829768777691712,0.0160105204082656,-0.0396783077771177,0.0230829322232834,0.604278541077378
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X6155#5.Vitamin and mineral supplements_Vitamin E,51754,-0.0354023136454526,0.0164902403724645,-0.067723184775483,-0.00308144251542218,0.031814415332567
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X6155#6.Vitamin and mineral supplements_Folic acid or Folate (Vit B9),51754,-0.0235169969168553,0.0197690958421554,-0.0622644247674799,0.0152304309337693,0.234222199200017
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X6155#7.Vitamin and mineral supplements_Multivitamins + or - minerals,51754,0.0221504828476529,0.00576607311448674,0.0108489795432589,0.0334519861520469,0.000122600912045895
PON2,Serum paraoxonase/arylesterase 2,Lifestyle factors,X6157#1.Why stopped smoking_Illness or ill health,34086,-0.000839186985383986,0.014607189073048,-0.029469277568558,0.02779090359779,0.954188610118764
PON2,Serum paraoxonase/arylesterase 2,Lifestyle factors,X6157#2.Why stopped smoking_Doctor's advice,34086,0.0234415627273201,0.0175554810542046,-0.010967180138921,0.0578503055935612,0.181838632407934
PON2,Serum paraoxonase/arylesterase 2,Lifestyle factors,X6157#3.Why stopped smoking_Health precaution,34086,-0.0163991637564111,0.0130277369058395,-0.0419335280918566,0.00913520057903433,0.208160343153589
PON2,Serum paraoxonase/arylesterase 2,Lifestyle factors,X6157#4.Why stopped smoking_Financial reasons,34086,0.000688429637660175,0.0115402236687055,-0.0219304087530026,0.0233072680283229,0.952432751518052
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X6159#1.Pain type(s) experienced in last month_Headache,51858,0.0190177815231481,0.00700563809631404,0.00528673085437261,0.0327488321919236,0.00663968898892673
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X6159#2.Pain type(s) experienced in last month_Facial pain,51858,0.0186151291174186,0.0229305854422453,-0.0263288183493822,0.0635590765842194,0.416912711590834
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X6159#3.Pain type(s) experienced in last month_Neck or shoulder pain,51858,0.00216543070076906,0.00616890601286148,-0.00992562508443944,0.0142564864859776,0.725573931716192
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X6159#4.Pain type(s) experienced in last month_Back pain,51858,0.00301454551533027,0.00576273268033654,-0.00828041053812934,0.0143095015687899,0.600902397774381
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X6159#5.Pain type(s) experienced in last month_Stomach or abdominal pain,51858,0.034166475169241,0.00975087956780112,0.0150547512163508,0.0532781991221312,0.000459293870278768
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X6159#6.Pain type(s) experienced in last month_Hip pain,51858,0.00356792400207856,0.00880499298727651,-0.0136898622529834,0.0208257102571405,0.685322475105246
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X6159#7.Pain type(s) experienced in last month_Knee pain,51858,0.00509263989868733,0.00621951797557321,-0.00709761533343616,0.0172828951308108,0.412899875907722
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X6159#8.Pain type(s) experienced in last month_Pain all over the body,51858,0.0298207736607451,0.0203832499222515,-0.0101303961868678,0.069771943508358,0.143479831163491
PON2,Serum paraoxonase/arylesterase 2,Lifestyle factors,X6160#1.Leisure or social activities_Sports club or gym,44791,-0.0411671417389625,0.00641297034766339,-0.0537365636203827,-0.0285977198575422,1.4065805648625e-10
PON2,Serum paraoxonase/arylesterase 2,Lifestyle factors,X6160#2.Leisure or social activities_Pub or social club,44791,0.0153044316628172,0.00630824254966056,0.00294027626548248,0.0276685870601519,0.0152728844262126
PON2,Serum paraoxonase/arylesterase 2,Lifestyle factors,X6160#3.Leisure or social activities_Religious group,44791,0.00920550600810289,0.008163886718007,-0.00679571195919083,0.0252067239753966,0.259510391424672
PON2,Serum paraoxonase/arylesterase 2,Lifestyle factors,X6160#4.Leisure or social activities_Adult education class,44792,-0.0171690621516756,0.0126366493090151,-0.0419368947973452,0.00759877049399409,0.174269460900809
PON2,Serum paraoxonase/arylesterase 2,Lifestyle factors,X6160#5.Leisure or social activities_Other group activity,44792,-0.0102014888673316,0.00720456099515574,-0.0243224284178368,0.00391945068317368,0.156801628010447
PON2,Serum paraoxonase/arylesterase 2,Physical activities,X6162#1.Types of transport used (excluding work)_Car or motor vehicle,51637,0.00323106300954237,0.00662535768560589,-0.00975463805424517,0.0162167640733299,0.625780244447908
PON2,Serum paraoxonase/arylesterase 2,Physical activities,X6162#2.Types of transport used (excluding work)_Walk,51637,-0.0119505564002754,0.0052041708003665,-0.0221507311689938,-0.0017503816315571,0.0216652618513238
PON2,Serum paraoxonase/arylesterase 2,Physical activities,X6162#3.Types of transport used (excluding work)_Public transport,51637,-0.00201670701458306,0.00588022227557458,-0.0135419426747092,0.00950852864554311,0.731628357596649
PON2,Serum paraoxonase/arylesterase 2,Physical activities,X6162#4.Types of transport used (excluding work)_Cycle,51637,-0.0512441929780198,0.00897672946714331,-0.0688385827336207,-0.0336498032224189,1.15336331176712e-08
PON2,Serum paraoxonase/arylesterase 2,Physical activities,X6164#1.Types of physical activity in last 4 weeks_Walking for pleasure (not as a means of transport),51660,-0.0246380069270823,0.00560763109922483,-0.035628963881563,-0.0136470499726016,1.11956632138208e-05
PON2,Serum paraoxonase/arylesterase 2,Physical activities,X6164#3.Types of physical activity in last 4 weeks_Strenuous sports,51660,-0.0424435192696133,0.00783262214480267,-0.0577954586734266,-0.0270915798658001,6.05968262316775e-08
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X6179#1.Mineral and other dietary supplements_Fish oil (including cod liver oil),51754,-0.0414709007802506,0.00571644880668269,-0.0526751404413487,-0.0302666611191525,4.1534105244475e-13
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X6179#2.Mineral and other dietary supplements_Glucosamine,51754,-0.0225733962367254,0.00718782440622141,-0.0366615320729194,-0.00848526040053144,0.00168869174448557
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X6179#3.Mineral and other dietary supplements_Calcium,51754,-0.0214099823093813,0.0152544676119981,-0.0513087388288975,0.00848877421013492,0.160474619401841
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X6179#4.Mineral and other dietary supplements_Zinc,51754,-0.0540489353835676,0.0139641253216912,-0.0814186210140824,-0.0266792497530528,0.000108885004298901
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X6179#5.Mineral and other dietary supplements_Iron,51754,-0.0279134734447982,0.0169711356267781,-0.0611768992732832,0.00534995238368692,0.100032543551001
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X6179#6.Mineral and other dietary supplements_Selenium,51754,-0.0796816654564753,0.0175846018450602,-0.114147485072793,-0.0452158458401573,5.89059086337176e-06
PON2,Serum paraoxonase/arylesterase 2,Physical measures,"X78.Heel bone mineral density (BMD) T-score, automated",41775,-0.00856664521806037,0.00344216413415639,-0.0153132869210069,-0.00182000351511385,0.0128319855200992
PON2,Serum paraoxonase/arylesterase 2,Physical activities,X864.Number of days or week walked 10+ minutes,51396,-0.0380622295932968,0.0311369804200143,-0.0990907112165248,0.0229662520299313,0.221564370983512
PON2,Serum paraoxonase/arylesterase 2,Physical activities,X874.Duration of walks,48805,0.0070298710404017,0.00267863228880102,0.0017797517543517,0.0122799903264517,0.00868605532187568
PON2,Serum paraoxonase/arylesterase 2,Physical activities,X884.Number of days or week of moderate physical activity 10+ minutes,50814,-0.127104973716166,0.0301834275794648,-0.186264491771917,-0.0679454556604148,2.5514794177311e-05
PON2,Serum paraoxonase/arylesterase 2,Physical activities,X894.Duration of moderate activity,46106,0.0375448634316459,0.0363415777523198,-0.0336846289629008,0.108774355826193,0.301566490087664
PON2,Serum paraoxonase/arylesterase 2,Physical activities,X90087.No-wear time bias adjusted average acceleration,33224,-0.0108655788561153,0.00588368446313071,-0.0223976004038515,0.000666442691620934,0.0648500816564074
PON2,Serum paraoxonase/arylesterase 2,Physical activities,X904.Number of days or week of vigorous physical activity 10+ minutes,50737,-0.236766749709753,0.0309169045889235,-0.297363882704043,-0.176169616715463,1.96325507816971e-14
PON2,Serum paraoxonase/arylesterase 2,Physical activities,X914.Duration of vigorous activity,41846,-0.00707663927531033,0.00318521441146648,-0.0133196595217846,-0.000833619028836039,0.0263193920871035
